OBO_ID (LABEL):	CL_0000084 (T cell)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2409299	5/2008	S102-PMC2409299	['in a small cohort of healthy young gambian men from the same population (n = 25), no effect of Perinatal nutritional exposures (assessed by season of birth and Birth weight) was observed on T Lymphocyte kinetics [31].']	N/A	N/A	[('GO_0036268', 'swimming', 95, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 95, 'perinatal'), ('GO_0007567', 'parturition', 160, 'birth'), ('CL_0000084', 'T cell', 190, 'T lymphocyte')]
PMC2409299	5/2008	S126-PMC2409299	['laboratory methods\nT-Lymphocyte (cd3+, Cd4+, Cd8+, B-Cell (Cd19+), and Natural Killer Cell (Cd56+) subpopulations were enumerated in whole Blood samples at Birth (Cord Blood) and at 8, 16 and 52 weeks of age by flow cytometry (facscalibur, beckton dickinson uk ltd, oxford, uk) using appropriate isotypic controls (cyto-stat, beckman-coulter international s.a., nyon, switzerland).']	N/A	N/A	[('CL_0000084', 'T cell', 19, 'T-lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 39, 'CD4'), ('PR_000005170', 'CD37 molecule', 45, 'CD8'), ('CL_0000236', 'B cell', 51, 'B-cell'), ('PR_000001309', 'CD70 molecule', 59, 'CD19'), ('CL_0000623', 'natural killer cell', 71, 'natural killer cell'), ('PR_000001309', 'CD70 molecule', 92, 'CD56'), ('UBERON_0000178', 'blood', 139, 'blood'), ('GO_0007567', 'parturition', 156, 'birth'), ('UBERON_0002240', 'spinal cord', 163, 'cord'), ('UBERON_0000178', 'blood', 168, 'blood')]
PMC2685863	5/2009	S10-PMC2685863	['each T Cell is made with a unique Antigen receptor that allows the Immune System to react quickly to any foreign protein a Person might encounter.']	N/A	N/A	[('CL_0000084', 'T cell', 5, 'T cell'), ('CHEBI_59132', 'antigen', 34, 'antigen'), ('UBERON_0002405', 'immune system', 67, 'immune system'), ('NCBITaxon_10088', 'Mus <genus>', 123, 'person')]
PMC2721967	7/2009	S14-PMC2721967	['in the Thymus, Bone Marrow-derived precursors undergo differentiation and selection, ultimately leading to the migration of positively selected Thymocytes to the T-Cell-dependent areas of the peripheral lymphoid Organs (4,5).']	N/A	N/A	[('UBERON_0002370', 'thymus', 7, 'thymus'), ('UBERON_0002371', 'bone marrow', 15, 'bone marrow'), ('CL_0000893', 'thymocyte', 144, 'thymocytes'), ('CL_0000084', 'T cell', 162, 'T-cell'), ('UBERON_0010131', 'conducting tissue of heart', 212, '... organs')]
PMC2721967	7/2009	S136-PMC2721967	['the primary role of the Human Thymus is the site for the Differentiation Of Bone-Marrow-derived T-Cell precursors into positively selected Thymocytes.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 24, 'human'), ('UBERON_0002370', 'thymus', 30, 'thymus'), ('GO_0030154', 'cell differentiation', 57, 'differentiation of ... cell ...'), ('UBERON_0002371', 'bone marrow', 76, 'bone-marrow'), ('CL_0000084', 'T cell', 96, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 97, '-'), ('CL_0000893', 'thymocyte', 139, 'thymocytes')]
PMC2721967	7/2009	S137-PMC2721967	['this process involves sequential Expression of various proteins and rearrangements of T-Cell receptor Genes (5).']	N/A	N/A	[('GO_0010467', 'gene expression', 33, 'expression'), ('CL_0000084', 'T cell', 86, 'T-cell'), ('GO_0005622', 'intracellular anatomical structure', 87, '-cell'), ('SO_0000704', 'gene', 102, 'genes')]
PMC2721967	7/2009	S175-PMC2721967	['trecs are formed during the generation and Expression of the T-Cell Antigen receptor (31) and levels in Peripheral Blood T-Cells are increasingly used as a direct measure of Thymic output.']	N/A	N/A	[('GO_0010467', 'gene expression', 43, 'expression'), ('CL_0000084', 'T cell', 61, 'T-cell'), ('GO_0085026', 'tubovesicular membrane network', 61, 'T-cell'), ('CHEBI_59132', 'antigen', 68, 'antigen'), ('UBERON_0012101', 'perinatal stage', 104, 'peripheral blood'), ('CL_0000084', 'T cell', 121, 'T-cells'), ('GO_0005618', 'cell wall', 122, '-cells'), ('UBERON_0002370', 'thymus', 174, 'thymic')]
PMC2779500	11/2009	S82-PMC2779500	['uninfected Cd4+\nCd4+T Cells are produced by the Thymus at constant rate λx, are eliminated from the system at per-capita rate dxand become infected through mass-action kinetics at rate β (1 - ϵ) xy , where the infection rate β is a function of r , described below, and ϵ is the effectiveness of Drug therapy.']	N/A	N/A	[('CL_0000476', 'thyrotroph', 11, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 11, 'CD4'), ('CL_0000476', 'thyrotroph', 16, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 16, 'CD4'), ('CL_0000084', 'T cell', 20, 'T cells'), ('UBERON_0002370', 'thymus', 48, 'thymus'), ('CHEBI_23888', 'drug', 295, 'drug')]
PMC2779500	11/2009	S83-PMC2779500	['infected Cd4+\nCd4+T Cells become Infected at rate β (1 - ϵ) xy .']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 9, 'CD4'), ('CL_0000476', 'thyrotroph', 14, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 14, 'CD4'), ('CL_0000084', 'T cell', 18, 'T cells'), ('GO_0007631', 'feeding behavior', 33, 'infected')]
PMC2779500	11/2009	S86-PMC2779500	['in the event of infection, Ros are also produced by infected cells at a rate proportional to the number of infected Cd4+T Cells, ky .']	N/A	N/A	[('CHEBI_8756', 'RNA (poly(A))', 27, 'ROS'), ('CL_0000476', 'thyrotroph', 116, 'CD4 ...'), ('CL_0000084', 'T cell', 120, 'T cells')]
PMC2779500	11/2009	S133-PMC2779500	['finding xp, yp, xvand yv\nthe clinical data in table2give only the sum of cd4+ T Cells, xp+ ypand xv+ yv.']	N/A	N/A	[('CL_0000084', 'T cell', 78, 'T cells')]
PMC2779500	11/2009	S143-PMC2779500	["twelve months of treatment were shown, on average, to increase these patients' cd4+T Cell counts from 231 ± 87 cells/ μ l to 345 ± 62 cells/ μ l, which is approximately the same level as in the hiv(+) groups in jaruga et al."]	N/A	N/A	[('CL_0000573', 'retinal cone cell', 82, '+'), ('CL_0000084', 'T cell', 83, 'T cell')]
PMC2779500	11/2009	S165-PMC2779500	['at these parameter values and antioxidant supplementation levels, only one biologically meaningful internal equilibrium exists, and this equilibrium agrees well with the cd4+T Cell and antioxidant concentrations in jaruga et al.']	N/A	N/A	[('CL_0000084', 'T cell', 174, 'T cell')]
PMC2779500	11/2009	S188-PMC2779500	['when we supplement the diet with 58 mg of absorbed Antioxidants per day, an increase in the level of uninfected Cd4+T Cells (to 345 cells/ μ l) is observed.']	N/A	N/A	[('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 51, 'antioxidants'), ('CL_0000476', 'thyrotroph', 112, 'CD4 ...'), ('CL_0000084', 'T cell', 116, 'T cells')]
PMC2779500	11/2009	S300-PMC2779500	["for example, consider the limit cycle in figure5b: in this case, a patient's Immunological Response is periodically compromised - characterized by a low concentration of uninfected Cd4+T Cells - leaving the Individual vulnerable to opportunistic infections."]	N/A	N/A	[('GO_0006955', 'immune response', 77, 'immunological response'), ('CL_0000476', 'thyrotroph', 181, 'CD4 ...'), ('CL_0000084', 'T cell', 185, 'T cells'), ('NCBITaxon_1', 'root', 207, 'individual')]
PMC2779500	11/2009	S302-PMC2779500	['in this figure, populations during the limit Cycle are rescaled to facilitate comparison, while white vertical bars delineate the peak and trough concentrations of Infected T Cells.']	N/A	N/A	[('GO_0007049', 'cell cycle', 45, 'cycle'), ('GO_0007631', 'feeding behavior', 164, 'infected'), ('CL_0000084', 'T cell', 173, 'T cells')]
PMC2999828	3/2009	S12-PMC2999828	['classification and mechanism\nhypersensitivity against Allergens can be mediated by either Antibodies or T Lymphocytes.']	N/A	N/A	[('CHEBI_33663', 'cyclic hydrocarbon', 54, 'allergens'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibodies'), ('CL_0000084', 'T cell', 104, 'T lymphocytes')]
PMC3131279	7/2011	S57-PMC3131279	['no other Genes were among the twenty most altered Genes in more than one generation.10.1371/journal.pone.0021668.t001\n\ncaption (table-Wrap): table 1\nHepatic Genes showing the greatest difference between pr and ps offspring.difference between ps and pr offspring (fold differences between pr and ps)f1f2f3up-regulateddown-regulatedup-regulateddown-regulatedup-regulateddown-regulatedcytochrome P450, 3,A nm_153312 (69.4)Transmembrane Protein 27 nm_020976 (174.3) Trefoil Factor 2 nm_053844 (13.9) Olfactory receptor 144 nm_001000164 (15.3)Surfactant associated protein c nm_017342 (25.1)Pancreatic Lipase Related Protein 1 nm_032081 (47.5)α2μ globulin nm_001024248 (40.2)Uromodulin nm_017082 (105.3)Hyaluronan mediated motility receptor nm_012964 (12.9)Egf-Like Domain 7 nm_139104 (14) Lymphocyte-Activation Gene 3 nm_212513 (17.4) Pancreatic lipase nm_013161 (39.6)α2μ globulin Pgcl4 nm_147215 (38.3)Cytochrome P450 (11B) nm_012537 (104.9)Sarcolipin nm_001013247 (10.0)Type i keratin Ka11 nm_001008750 (7.1)Caveolin 3 nm_019155 (11.2) Pancreatic Amylase 2 nm_031502 (39.4)Lymphocyte-Activation Gene 3 nm_212513 (35.9) Chromogranin B nm_012526 (98.8)Cathepsin R nm_001017509 (7.9)T-Cell receptor Β-Chain mrna v-region m23885 (6.6)Telethonin xm_001081394 (9.9)Glycoprotein 2 nm_134418 (38.5)Α2Μ Globulin Pgcl3 nm_147212 (29.1)Chloride channel kb nm_173103 (98.1)Threonyl-Trna Synthetase-Like 2 nm_001014020 (7.6)Stathmin-Like 3 nm_024346 (5.5)Bile Acid Coenzyme A: amino acid n-acyltransferasexm_001055067 (9.7)Cationic Trypsinogen nm_173127 (34.4)α2μ globulin Pgcl1 nm_147214 (16.4)Solute Carrier Family 7 (y+ system) member 13 nm_001012100 (92.6) Lymphocyte-Activation Gene 3 nm_212513 (7.5) Myelin-Associated Basic Protein-99 X89638 (5.2)riken nm_001039686 (7.9)Serine Protease-2 nm_012729 (26.0)myosin ixb xm_346173 (15.2)Defensin Β1 nm_031810 (81.4)C-Myc Promoter binding protein xr_009072 (7.3)Cystatin nm_133566 (5.0)Myosin, Light Polypeptide 3 nm_012606 (7.9)Pancreatic Trypsin 1 nm_012635 (24.8)α2μ globulin Pgcl5 nm_147213 (12.8)Solute Carrier Family 26 (4) nm_019214 (80.1)Gastrokine 1 Xm_001074955 (6.4)Socs Box-Containing Protein 3 Xm_344277 (4.5)Immunoglobulin variable region z93370 (7.8)Pancreatic lipase-related Protein-2 nm_057206 (22.5)Caldesmon 1 nm_013146 (12.3)Protein Phosphatase 1, Regulatory Subunit 1A nm_022676 (76.6)Membrane-associated dhhc17 zinc finger protein nm_001039340 (5.8)Fun14 Domain Containing-1 nm_001025027 (4.5)Pancreatitis-Associated Protein nm_053289 (7.8)Ribonuclease A nm_001029904 (19.8)Major Urinary Protein 5 nm_203325 (11.3)Solute Carrier Family 3 nm_017216 (71.0)unknown af433878 (5.3)arachidonate 5-lipoxygenase nm_012822 (4.5)Actin-Α Cardiac- 1 nm_019183 (7.7)Chymotrypsin C nm_001077649 (19.1)Cytochrome P450 (2C13) nm_138514 (10.4)Kidney Androgen Regulated Protein nm_052802 (67.6)Glycosylation Dependent Cell Adhesion Molecule 1 nm_012794 (5.2)Protocadherin-Α nm_201422 (4.5)Ec1-V2R Pheromone Receptor Xm_236825 (7.0)Pancreatic Elastase-1 nm_012552 (18.9)α2μ globulin (l type) nm_001003409 (10.1)Deoxyribonuclease 1 nm_013097 (60.8)Actin Α Cardiac 1 nm_019183 (5.2)Thioesterase Superfamily Member 4 (Them4), mrna nm_001025017 (4.4)S100 Calcium Binding protein g nm_012521 (7.0)Chymotrypsin-Like nm_054009 (17.0)Kpl2 protein nm_022620 (10.0)Degenerative Spermatocyte Homolog 2 nm_001017457 (58.0)serine dehydratase x13119 (5.0)Endothelial differentiation, Sphingolipid G-Protein-Coupled Receptor, 8 nm_021775 (4.3) Trefoil Factor 2 nm_053844 (6.9) Carboxypeptidase B1 nm_012533 (16.5)Cytochrome P450 (iic) nm_019184 (8.1)solute carrier family 5 (Sodium/Glucose co-Transporter), nm_022590 (57.6)phosphodiesterase 4d interacting protein nm_022382 (4.9)Olfactory Receptor 74 nm_001000134 (4.3)Type i keratin Ka15 nm_001004022 (6.9)Trypsin 10 nm_001004097 (16.5)protein tyrosine kinase c-yes xm_343644 (7.5)Tonin nm_012677 (49.7)Olfactory receptor 1250 nm_001000806 (4.8)Olfactory Receptor 821 nm_001000842 (4.3)Topoisomerase -2Α nm_022183 (6.7)chymotrypsinogen b nm_012536 (15.1)Diamine Acetyltransferase 1 Xm_228448 (7.0)myosin, heavy polypeptide 7 nm_017240 (48.1)pparγ1 co-activator 1α nm_031347 (4.6)Kiss1 receptor nm_023992 (4.2)cleavage and Polyadenylation specificity Factor 3 Xr_005746 (6.3)Elastase 2 nm_012553 (11.9) Pancreatic Amylase 2 nm_031502 (6.8) Cadherin 16 nm_001012055 (47.6)Olfactory receptor 1467 nm_001000025 (4.6)Calmodulin-sensitive Plasma Membrane Ca2+-Transporting atpase j05087 (4.2)atp-binding Cassette (Sub-Family B, Member 11) xm_579531 (6.2)Pancreatic colipase nm_013139 (10.6)absent 1 Isoform b xm_232591 (6.8)Solute Carrier Family 7 (y+ system), member 12 nm_001017465 (47.1)Cysteine And Tyrosine-Rich Protein 1 nm_001013980 (4.6)Seminal Vesicle Protein 4 nm_012662 (4.1)Annexin A8 nm_001031654 (6.1)syncollin nm_139086 (9.4)Glandular Kallikrein 11 nm_001003977 (5.5)Hydroxyacid Oxidase-2 nm_032082 (45.1)Neurogenic Differentiation- 2 nm_019326 (4.6)Rt1 class ib Gene nm_012646 (4.1)Olfactory receptor 272 nm_001000230 (6.0)serpin x99773 (9.2)Rab3A nm_013018 (5.5)Solute Carrier Family 12, Member 1 nm_019134 (41.9)Rt1 Class Ii, locus dob nm_001008846 (4.3)Dual Oxidase 1 nm_153739 (4.1)lectin, Galactose binding, soluble 4 nm_012975 (5.8)Carboxyl Ester lipase nm_016997 (9.2)\nGenes which were among the twenty most different between pr and ps offspring in more than one generation are in bold font.']	N/A	N/A	[('SO_0000704', 'gene', 9, 'genes'), ('SO_0000704', 'gene', 50, 'genes'), ('PR_000017453', 'protein Wnt-9b', 134, 'WRAP'), ('UBERON_0002107', 'liver', 149, 'Hepatic'), ('SO_0000704', 'gene', 157, 'genes'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 393, 'P450'), ('PR_000013139', "serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha", 393, 'P450, 3,a'), ('GO_0032588', 'trans-Golgi network membrane', 419, 'Transmembrane'), ('PR_000029823', 'E3 ubiquitin ligase TRIM40', 419, 'Transmembrane protein 27'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 462, 'Trefoil factor 2'), ('GO_0007608', 'sensory perception of smell', 496, 'Olfactory'), ('CHEBI_35195', 'surfactant', 538, 'Surfactant'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 586, 'Pancreatic lipase related protein 1'), ('UBERON_0001264', 'pancreas', 586, 'Pancreatic'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 670, 'Uromodulin'), ('CHEBI_5828', 'Hymexazol O-glucoside', 698, 'Hyaluronan'), ('PR_000006911', 'selenocysteine-specific elongation factor', 752, 'EGF-like domain 7'), ('SO_0000417', 'polypeptide_domain', 761, 'domain'), ('CL_0000824', 'mature natural killer cell', 785, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 785, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 785, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 807, 'gene'), ('UBERON_0001264', 'pancreas', 831, 'Pancreatic'), ('PR_000012388', 'protocadherin gamma-A10', 878, 'PGCL4'), ('CHEBI_4056', 'cytochrome', 900, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 900, 'Cytochrome P450'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 917, '11B'), ('PR_000000364', 'smad2', 939, 'Sarcolipin'), ('PR_000016580', 'tropomyosin beta chain', 969, 'Type'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 984, 'KA11'), ('PR_000004967', 'calbindin', 1007, 'Caveolin 3'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 1035, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 1035, 'Pancreatic'), ('CL_0000824', 'mature natural killer cell', 1072, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 1072, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 1072, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 1094, 'gene'), ('CHEBI_68805', 'chaetomugilin A', 1118, 'Chromogranin B'), ('PR_000001204', 'C-C chemokine receptor type 8', 1149, 'Cathepsin R'), ('CL_0000084', 'T cell', 1179, 'T-cell'), ('PR_000003676', 'actin, cytoplasmic 1', 1195, 'β-chain'), ('PR_000016393', 'transmembrane channel-like protein 2', 1229, 'Telethonin'), ('CHEBI_17089', 'glycoprotein', 1258, 'Glycoprotein'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 1258, 'Glycoprotein 2'), ('PR_000001990', 'C-C motif chemokine 18', 1289, 'α2μ'), ('CHEBI_5386', 'globin', 1293, 'globulin'), ('PR_000012591', 'pepsin A-5', 1302, 'PGCL3'), ('CHEBI_17996', 'chloride', 1324, 'Chloride'), ('PR_000016296', 'protein-glutamine gamma-glutamyltransferase 5', 1360, 'Threonyl-tRNA synthetase-like 2'), ('PR_000015293', 'sphingomyelin phosphodiesterase 2', 1410, 'Stathmin-like 3'), ('CHEBI_3098', 'bile acid', 1441, 'Bile acid'), ('UBERON_0001970', 'bile', 1441, 'Bile'), ('CHEBI_15346', 'coenzyme A', 1451, 'Coenzyme A'), ('CHEBI_36916', 'cation', 1509, 'Cationic'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 1518, 'trypsinogen'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 1559, 'PGCL1'), ('PR_000015439', 'nuclear body protein SP140-like protein', 1581, 'Solute carrier family 7 ...'), ('CL_0000824', 'mature natural killer cell', 1647, 'Lymphocyte'), ('PR_000004680', 'breast carcinoma-amplified sequence 3', 1657, '-activation gene 3'), ('SO_0000704', 'gene', 1669, 'gene'), ('PR_000029266', 'alkylglycerol monooxygenase', 1692, 'Myelin-associated Basic Protein-99 X89638'), ('UBERON_0000345', 'myelin', 1692, 'Myelin'), ('PR_000014506', 'secretoglobin family 1D member 1', 1763, 'Serine protease-2'), ('PR_000006525', 'delta-like protein 4', 1824, 'Defensin β1'), ('PR_000000084', 'c-myc protein', 1852, 'C-myc'), ('SO_0000167', 'promoter', 1858, 'promoter'), ('PR_000005890', 'crooked neck-like protein 1', 1898, 'Cystatin'), ('PR_000010876', 'myoferlin', 1922, 'Myosin, light polypeptide 3'), ('PR_000014709', 'neuroserpin', 1965, 'Pancreatic'), ('UBERON_0001264', 'pancreas', 1965, 'Pancreatic'), ('PR_000027795', 'trypsin', 1976, 'trypsin 1'), ('PR_000012388', 'protocadherin gamma-A10', 2015, 'PGCL5'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 2037, 'Solute carrier family 26'), ('PR_000007220', 'ethanolamine kinase 2', 2082, 'Gastrokine 1 XM_001074955'), ('PR_000029264', 'AT-hook DNA-binding motif-containing protein 1', 2113, 'SOCS box-containing protein 3 XM_344277'), ('GO_0019815', 'B cell receptor complex', 2158, 'Immunoglobulin'), ('UBERON_0001264', 'pancreas', 2201, 'Pancreatic'), ('PR_000014700', 'serpin B9', 2227, 'protein-2'), ('PR_000002199', 'cytochrome c protein', 2253, 'Caldesmon 1'), ('PR_000013086', 'peptidyl-prolyl cis-trans isomerase-like 4', 2281, 'Protein phosphatase 1, regulatory subunit 1A'), ('GO_0065007', 'biological regulation', 2304, 'regulatory'), ('GO_0016020', 'membrane', 2342, 'Membrane'), ('PR_000007693', 'ferritin, mitochondrial', 2407, 'FUN14 domain containing-1'), ('SO_0000417', 'polypeptide_domain', 2413, 'domain'), ('PR_000013199', 'prolargin', 2451, 'Pancreatitis-associated protein'), ('PR_000023799', 'ribonuclease R', 2498, 'Ribonuclease A'), ('PR_000010045', 'transcription factor Maf', 2532, 'Major urinary protein 5'), ('UBERON_0001088', 'urine', 2538, 'urinary'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 2572, 'Solute carrier family 3'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 2677, 'Actin-α cardiac- 1'), ('UBERON_0000948', 'heart', 2685, 'cardiac'), ('PR_000006022', 'lysosomal protective protein', 2711, 'Chymotrypsin C'), ('CHEBI_4056', 'cytochrome', 2745, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 2745, 'Cytochrome P450'), ('PR_000005173', 'CD59 glycoprotein', 2762, '2c13'), ('PR_000009204', 'lysine-specific demethylase 5A', 2784, 'Kidney androgen regulated protein'), ('UBERON_0002113', 'kidney', 2784, 'Kidney'), ('CHEBI_50113', 'androgen', 2791, 'androgen'), ('GO_0065007', 'biological regulation', 2800, 'regulated'), ('GO_0006277', 'DNA amplification', 2834, 'Glycosylation'), ('PR_000007775', 'gamma-aminobutyric acid receptor subunit delta', 2834, 'Glycosylation dependent cell adhesion molecule 1'), ('CHEBI_36357', 'polyatomic entity', 2872, 'molecule'), ('PR_000012194', 'P2X purinoceptor 7', 2898, 'Protocadherin-α'), ('PR_000006897', 'endothelin-1', 2929, 'EC1-'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2933, 'V2R pheromone receptor XM_236825'), ('PR_000012529', 'PDZK1-interacting protein 1', 2971, 'Pancreatic elastase-1'), ('UBERON_0001264', 'pancreas', 2971, 'Pancreatic'), ('PR_000006605', 'dynamin-binding protein', 3050, 'Deoxyribonuclease 1'), ('PR_000003564', 'ATP-binding cassette sub-family C member 9', 3086, 'Actin α cardiac 1'), ('UBERON_0000948', 'heart', 3094, 'cardiac'), ('PR_000016139', 'TATA box-binding protein-like 2', 3119, 'Thioesterase superfamily member 4'), ('PR_000016329', 'T-lymphoma invasion and metastasis-inducing protein 2', 3154, 'Them4'), ('PR_000014411', 'protein S100-A4', 3185, 'S100 calcium binding'), ('PR_000005875', 'cysteine-rich protein 3', 3231, 'Chymotrypsin-like'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 3265, 'KPL2'), ('PR_000006460', 'dihydroorotate dehydrogenase (quinone), mitochondrial', 3294, 'Degenerative spermatocyte homolog 2'), ('CL_0000017', 'spermatocyte', 3307, 'spermatocyte'), ('SO_0000853', 'homologous_region', 3320, 'homolog'), ('UBERON_0001986', 'endothelium', 3380, 'Endothelial'), ('CHEBI_26739', 'sphingolipid', 3409, 'sphingolipid'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 3409, 'sphingolipid G-protein-coupled receptor, 8'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 3468, 'Trefoil factor 2'), ('PR_000005347', 'centrosome-associated protein CEP250', 3501, 'Carboxypeptidase B1'), ('CHEBI_4056', 'cytochrome', 3537, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 3537, 'Cytochrome P450'), ('CHEBI_52632', 'potassium-39 atom', 3599, 'sodium'), ('CHEBI_17234', 'glucose', 3606, 'glucose'), ('PR_000014938', 'urea transporter 1', 3617, 'transporter'), ('GO_0007608', 'sensory perception of smell', 3703, 'Olfactory'), ('PR_000014368', 'RuvB-like 1', 3713, 'receptor'), ('PR_000016580', 'tropomyosin beta chain', 3743, 'Type'), ('PR_000009486', 'keratin, type II cytoskeletal 71', 3758, 'KA15'), ('PR_000016869', 'thioredoxin-like protein 4A', 3781, 'Trypsin 10'), ('PR_000016331', 'tigger transposable element-derived protein 1', 3856, 'Tonin'), ('GO_0007608', 'sensory perception of smell', 3878, 'Olfactory'), ('GO_0007608', 'sensory perception of smell', 3920, 'Olfactory'), ('PR_000029714', 'roquin-2', 3930, 'receptor 821'), ('PR_000016842', 'trafficking regulator of GLUT4 1', 3961, 'Topoisomerase -2α'), ('CHEBI_4514', 'dicyclomine', 4029, 'Diamine'), ('PR_000029427', 'DnaJ homolog subfamily C member 7', 4029, 'Diamine acetyltransferase 1 XM_228448'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 4154, 'KISS1'), ('GO_0043631', 'RNA polyadenylation', 4197, 'polyadenylation'), ('PR_000049700', 'protein Wnt-9b, signal peptide removed form (human)', 4225, 'factor 3 XR_005746'), ('PR_000007002', 'eukaryotic translation initiation factor 5', 4249, 'Elastase 2'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 4277, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 4277, 'Pancreatic'), ('PR_000004968', 'calretinin', 4314, 'Cadherin 16'), ('GO_0007608', 'sensory perception of smell', 4345, 'Olfactory'), ('PR_000004967', 'calbindin', 4387, 'Calmodulin'), ('GO_0005886', 'plasma membrane', 4408, 'plasma membrane'), ('CHEBI_81233', 'Schizonepetoside B', 4424, 'Ca2+-'), ('GO_0016554', 'cytidine to uridine editing', 4424, 'Ca2+-transporting'), ('SO_0005853', 'gene_cassette', 4473, 'cassette'), ('PR_000015900', 'putative synaptotagmin-14-like protein', 4483, 'sub-family B, member 11'), ('UBERON_0001264', 'pancreas', 4523, 'Pancreatic'), ('SO_0001060', 'sequence_variant', 4568, 'isoform'), ('PR_000015439', 'nuclear body protein SP140-like protein', 4593, 'Solute carrier family 7 ...'), ('PR_000005866', 'cAMP-responsive element modulator', 4659, 'Cysteine and tyrosine-rich protein 1'), ('PR_000014892', 'NAD-dependent protein deacetylase sirtuin-6', 4714, 'Seminal vesicle protein 4'), ('UBERON_0000997', 'mammalian vulva', 4714, 'Seminal'), ('PR_000004080', 'annexin A7', 4755, 'Annexin A8'), ('UBERON_0002530', 'gland', 4809, 'Glandular'), ('PR_000009309', 'kinesin-like protein KIF2B', 4819, 'kallikrein 11'), ('CHEBI_16240', 'hydrogen peroxide', 4851, 'Hydroxyacid'), ('PR_000008453', 'hepatitis A virus cellular receptor 1', 4851, 'Hydroxyacid oxidase-2'), ('GO_0001822', 'kidney development', 4889, 'Neurogenic'), ('PR_000011461', 'endonuclease III-like protein 1', 4889, 'Neurogenic differentiation- 2'), ('PR_000012993', 'DNA-directed RNA polymerase II subunit RPB7', 4934, 'RT1'), ('SO_0000704', 'gene', 4947, 'gene'), ('GO_0007608', 'sensory perception of smell', 4967, 'Olfactory'), ('PR_000013610', 'Ras-related protein Rab-34', 5027, 'RAB3A'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 5048, 'Solute carrier family 12, member 1'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 5099, 'RT1 class II'), ('PR_000006745', 'dual specificity protein phosphatase 19', 5141, 'Dual oxidase 1'), ('CHEBI_28260', 'galactose', 5179, 'galactose'), ('CHEBI_3385', 'carbachol', 5223, 'Carboxyl ester'), ('SO_0000704', 'gene', 5261, 'Genes')]
PMC3156327	4/2011	S58-PMC3156327	['in Uncommitted Naive cd4+T Cells, key cytokine Promoter regions are methylated and transcriptionally repressed.']	N/A	N/A	[('GO_0050917', 'sensory perception of umami taste', 3, 'uncommitted'), ('CL_0000540', 'neuron', 15, 'naive ...'), ('CL_0000084', 'T cell', 25, 'T cells'), ('SO_0000167', 'promoter', 47, 'promoter')]
PMC3272870	12/2011	S131-PMC3272870	['during Pregnancy, Cellular Immunity undergoes changes, as reflected by a decrease in T-Cell number.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('GO_0071975', 'cell swimming', 18, 'cellular immunity'), ('CL_0000084', 'T cell', 85, 'T-cell')]
PMC3277098	12/2011	S78-PMC3277098	['the dna-bound vdr/rxr heterodimers can also down regulate transcription; such is the case with T Cell Cytokine Production [38].']	N/A	N/A	[('CL_0000084', 'T cell', 95, 'T cell'), ('GO_0002369', 'T cell cytokine production', 95, 'T cell cytokine production')]
PMC3415261	7/2012	S53-PMC3415261	['the Embryonic Thymus in Humans appears around 6 weeks Gestation [22], and later, T-Lymphocyte differentiation begins.']	N/A	N/A	[('UBERON_0000922', 'embryo', 4, 'embryonic'), ('UBERON_0002370', 'thymus', 14, 'thymus'), ('NCBITaxon_9606', 'Homo sapiens', 24, 'humans'), ('GO_0007565', 'female pregnancy', 54, 'gestation'), ('CL_0000084', 'T cell', 81, 'T-lymphocyte'), ('GO_0042092', 'type 2 immune response', 81, 'T-lymphocyte')]
PMC3415261	7/2012	S54-PMC3415261	['at week 10, the Thymus has differentiated Cortical and Medullar zones with T Cells and, at week 13, T Cells colonize the fetal Liver, Spleen, and Bone Marrow [23].']	N/A	N/A	[('UBERON_0002370', 'thymus', 16, 'thymus'), ('UBERON_0001851', 'cortex', 42, 'cortical'), ('UBERON_0000958', 'medulla of organ', 55, 'medullar'), ('CL_0000084', 'T cell', 75, 'T cells'), ('CL_0000084', 'T cell', 100, 'T cells'), ('UBERON_0002107', 'liver', 127, 'liver'), ('UBERON_0002106', 'spleen', 134, 'spleen'), ('UBERON_0002371', 'bone marrow', 146, 'bone marrow')]
PMC3415261	7/2012	S56-PMC3415261	['we have observed that T Lymphocytes in neonatal Rat Spleen are found in very low proportions during the first two weeks of Life [24].']	N/A	N/A	[('CL_0000084', 'T cell', 22, 'T lymphocytes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 48, 'rat'), ('UBERON_0002106', 'spleen', 52, 'spleen'), ('UBERON_0000104', 'life cycle', 123, 'life')]
PMC3415261	7/2012	S62-PMC3415261	['in the second phase of the Suckling Period (i.e., 10–21 days), the number of Cd4+ and Cd8+ Cells increases, and Lymphocytes bearing cd3, Tcr Αβ , Cd5, and Cd2 Molecules appear in the Spleen (as can be seen in the T-Cell pattern offigure 1(a)) [24].']	N/A	N/A	[('GO_0001967', 'suckling behavior', 27, 'suckling'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 27, 'suckling period'), ('PR_000001204', 'C-C chemokine receptor type 8', 77, 'CD4'), ('PR_000005170', 'CD37 molecule', 86, 'CD8'), ('CL_0000573', 'retinal cone cell', 91, 'cells'), ('CL_0000542', 'lymphocyte', 112, 'lymphocytes'), ('PR_000016190', 'trichohyalin-like protein 1', 137, 'TCR αβ'), ('PR_000001204', 'C-C chemokine receptor type 8', 146, 'CD5'), ('PR_000001204', 'C-C chemokine receptor type 8', 155, 'CD2'), ('CHEBI_36357', 'polyatomic entity', 159, 'molecules'), ('UBERON_0002106', 'spleen', 183, 'spleen'), ('CL_0000084', 'T cell', 213, 'T-cell')]
PMC3415261	7/2012	S87-PMC3415261	['with respect to T-Cell Development, on day 21, 15% of pp cells are Cd5+, 12% are Cd4+ and only 4% are Cd8+ [45].']	N/A	N/A	[('CL_0000084', 'T cell', 16, 'T-cell'), ('GO_0002296', 'T-helper 1 cell lineage commitment', 16, 'T-cell development'), ('PR_000001204', 'C-C chemokine receptor type 8', 67, 'CD5'), ('PR_000001204', 'C-C chemokine receptor type 8', 81, 'CD4'), ('PR_000005170', 'CD37 molecule', 102, 'CD8')]
PMC3415261	7/2012	S108-PMC3415261	['Intestine Lamina Propria (Lp), placed between Epithelium and the Muscularis Mucosa , contains, when achieves mature state, Effector Cells as mature Iga-producing Plasma Cells, T Lymphocytes (mainly Th), Macrophages, Dendritic Cells, and Mast Cells [64].']	N/A	N/A	[('UBERON_0000160', 'intestine', 0, 'Intestine'), ('UBERON_0000030', 'lamina propria', 10, 'lamina propria'), ('UBERON_0004619', 'lumbar vertebra 3', 26, 'LP'), ('UBERON_0000483', 'epithelium', 46, 'epithelium'), ('UBERON_0006676', 'muscularis mucosa', 65, 'muscularis mucosa'), ('CHEBI_35224', 'effector', 123, 'effector'), ('CL_0000021', 'female germ cell', 123, 'effector cells'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 148, 'IgA'), ('CL_0000786', 'plasma cell', 162, 'plasma cells'), ('CL_0000084', 'T cell', 176, 'T lymphocytes'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 198, 'Th'), ('CL_0000235', 'macrophage', 203, 'macrophages'), ('CL_0000451', 'dendritic cell', 216, 'dendritic cells'), ('CL_0000097', 'mast cell', 237, 'mast cells')]
PMC3415261	7/2012	S112-PMC3415261	['Adult Rat lpls show a predominance of Cd4+ T Cells, followed by B Lymphocytes, a small proportion of Cd8+ cells and also a minor population of Nk Cells (figure 2(b)) [31,68].']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 6, 'rat'), ('PR_000001204', 'C-C chemokine receptor type 8', 38, 'CD4'), ('CL_0000084', 'T cell', 43, 'T cells'), ('CL_0000236', 'B cell', 64, 'B lymphocytes'), ('PR_000005170', 'CD37 molecule', 101, 'CD8'), ('CL_0000623', 'natural killer cell', 143, 'NK cells'), ('GO_0005634', 'nucleus', 143, 'NK')]
PMC3415261	7/2012	S124-PMC3415261	['T Cells in Intestine lp expand during the fetal period and have a density similar to the Postnatal Intestine by 19–27-week Gestation [46].']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T cells'), ('UBERON_0000160', 'intestine', 11, 'intestine'), ('GO_0007567', 'parturition', 89, 'postnatal'), ('UBERON_0000160', 'intestine', 99, 'intestine'), ('GO_0007565', 'female pregnancy', 123, 'gestation')]
PMC3420688	5/2012	S105-PMC3420688	['normal T Cells are activated by exposure to Antigens on the Surface Of Antigen-presenting Cells.']	N/A	N/A	[('CL_0000084', 'T cell', 7, 'T cells'), ('CHEBI_59132', 'antigen', 44, 'antigens'), ('GO_0009986', 'cell surface', 60, 'surface of ... cells'), ('CHEBI_59132', 'antigen', 71, 'antigen')]
PMC3420688	5/2012	S106-PMC3420688	['when activated, T Cells produce Il-2, which results in further Proliferation of their counterparts.']	N/A	N/A	[('CL_0000084', 'T cell', 16, 'T cells'), ('PR_000001470', 'interleukin-28B', 32, 'IL-2'), ('GO_0008283', 'cell proliferation', 63, 'proliferation')]
PMC3420688	5/2012	S113-PMC3420688	['T Cell Immune Suppression is therapeutic in 75% of cases of aa [23].']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T cell'), ('GO_0002457', 'T cell antigen processing and presentation', 0, 'T cell immune suppression')]
PMC3488908	4/2010	S38-PMC3488908	['ideally, acute Effector Responses are efficiently terminated after an Antigenic encounter, but lead to the generation of long-Lived Memory T Cells in preparation for future defense.']	N/A	N/A	[('CHEBI_35224', 'effector', 15, 'effector'), ('GO_0060033', 'anatomical structure regression', 24, 'responses'), ('CHEBI_59132', 'antigen', 70, 'antigenic'), ('GO_0007618', 'mating', 125, '-lived'), ('GO_0007613', 'memory', 132, 'memory'), ('CL_0000084', 'T cell', 139, 'T cells')]
PMC3488908	4/2010	S53-PMC3488908	['newer approaches are using whole Genome microarray technology to examine for differential Gene Expression in T Cells from Individuals with allergies (compared with Individuals without allergies).']	N/A	N/A	[('SO_0001026', 'genome', 33, 'genome'), ('GO_0010467', 'gene expression', 90, 'gene expression'), ('SO_0000704', 'gene', 90, 'gene'), ('CL_0000084', 'T cell', 109, 'T cells'), ('NCBITaxon_1', 'root', 122, 'individuals'), ('NCBITaxon_1', 'root', 164, 'individuals')]
PMC3534233	11/2012	S291-PMC3534233	['the sequence begins with Stimulation Of the Antigen Receptor (T Cell receptor (tcr)) with Major Histocompatibility Complex (Mhc) Molecules.']	N/A	N/A	[('GO_0001964', 'startle response', 25, 'stimulation of ... receptor'), ('CHEBI_59132', 'antigen', 44, 'antigen'), ('CL_0000084', 'T cell', 62, 'T cell'), ('GO_0085026', 'tubovesicular membrane network', 62, 'T cell'), ('GO_0007049', 'cell cycle', 64, 'cell'), ('GO_0042611', 'MHC protein complex', 90, 'major histocompatibility complex'), ('GO_0042611', 'MHC protein complex', 124, 'MHC'), ('CHEBI_36357', 'polyatomic entity', 129, 'molecules')]
PMC3534233	11/2012	S292-PMC3534233	['a second signal is needed for productive activation, mediated by the binding of Cd28 on the T Cell Surface to b7 proteins on the Antigen-presenting cell.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 80, 'CD28'), ('CL_0000084', 'T cell', 92, 'T cell'), ('GO_0097478', 'leaflet of membrane bilayer', 92, 'T cell surface'), ('CHEBI_59132', 'antigen', 129, 'antigen')]
PMC3534233	11/2012	S295-PMC3534233	['Tcr Signaling induces the production of the Cd28 Homologue Ctla4, a T Cell-specific Molecule with a higher binding affinity for B7, thereby outcompeting Cd28 and eventually inhibiting T Cell activity.']	N/A	N/A	[('GO_0038008', 'TRAF-mediated signal transduction', 0, 'TCR signaling'), ('PR_000001309', 'CD70 molecule', 44, 'CD28'), ('SO_0000853', 'homologous_region', 49, 'homologue'), ('PR_000006021', 'chymotrypsin-like protease CTRL-1', 59, 'CTLA4'), ('CL_0000084', 'T cell', 68, 'T cell'), ('CHEBI_36357', 'polyatomic entity', 84, 'molecule'), ('PR_000004693', 'Bcl-2-like protein 10', 128, 'B7'), ('PR_000001309', 'CD70 molecule', 153, 'CD28'), ('CL_0000084', 'T cell', 184, 'T cell')]
PMC3534233	11/2012	S296-PMC3534233	['this sequence of signals implies differentiated timing mechanisms, one signaling ‘turn on’, followed by a second signal to ‘accelerate’ a function when needed, and a braking function built into the mechanism that leads to the restriction of T Cell activity in order to minimize damage to normal Tissues.']	N/A	N/A	[('CL_0000084', 'T cell', 241, 'T cell'), ('UBERON_0000479', 'tissue', 295, 'tissues')]
PMC3553086	1/2013	S191-PMC3553086	['briefly, whole Blood, Peripheral Blood Mononuclear Cells (pbmc), Cd4+T Cells, Cd8+T-Cells, Cd56+Nk Cells, Cd19+B Cells, cd14+Monocytes, Granulocytes, Neutrophils and Eosinophils were isolated.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('CL_0000111', 'peripheral neuron', 22, 'peripheral blood'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CL_0000226', 'single nucleate cell', 39, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 39, 'mononuclear'), ('PR_000001204', 'C-C chemokine receptor type 8', 65, 'CD4'), ('CL_0000084', 'T cell', 69, 'T cells'), ('PR_000005170', 'CD37 molecule', 78, 'CD8'), ('CL_0000084', 'T cell', 82, 'T-cells'), ('PR_000001309', 'CD70 molecule', 91, 'CD56'), ('CL_0000623', 'natural killer cell', 96, 'NK cells'), ('GO_0005634', 'nucleus', 96, 'NK'), ('PR_000001309', 'CD70 molecule', 106, 'CD19'), ('CL_0000236', 'B cell', 111, 'B cells'), ('CL_0000576', 'monocyte', 125, 'monocytes'), ('CL_0000094', 'granulocyte', 136, 'granulocytes'), ('CL_0000775', 'neutrophil', 150, 'neutrophils'), ('CL_0000771', 'eosinophil', 166, 'eosinophils')]
PMC3553086	1/2013	S193-PMC3553086	['magnetic-Activated Cell sorting (macs, miltenyi biotech, germany) was used to obtain T Cells, B Cells, Monocytes, and Nk Cells from the pbmc:s and Neutrophils and Eosinophils from the Granulocyte containing pellet.']	N/A	N/A	[('CL_0000161', 'acid secreting cell', 9, 'activated cell'), ('CL_0000084', 'T cell', 85, 'T cells'), ('CL_0000236', 'B cell', 94, 'B cells'), ('CL_0000576', 'monocyte', 103, 'monocytes'), ('CL_0000623', 'natural killer cell', 118, 'NK cells'), ('GO_0005634', 'nucleus', 118, 'NK'), ('CL_0000775', 'neutrophil', 147, 'neutrophils'), ('CL_0000771', 'eosinophil', 163, 'eosinophils'), ('CL_0000094', 'granulocyte', 184, 'granulocyte')]
PMC3578836	2/2013	S4-PMC3578836	['f1 Mice from dams on the ms diet exhibited increased global T Cell Dna Methylation.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 3, 'mice'), ('CL_0000084', 'T cell', 60, 'T cell'), ('GO_0031295', 'T cell costimulation', 60, 'T cell DNA methylation')]
PMC3578836	2/2013	S10-PMC3578836	['inflammatory cytokines (Il-17, Tnf-Α, Il-6) were also lower in ms f1 Mice Serum and conditioned media from T-Cell culture.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 24, 'IL-17'), ('PR_000000134', 'tumor necrosis factor alpha', 31, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 38, 'IL-6'), ('NCBITaxon_10088', 'Mus <genus>', 69, 'mice'), ('UBERON_0001977', 'blood serum', 74, 'serum'), ('CL_0000084', 'T cell', 107, 'T-cell')]
PMC3578836	2/2013	S45-PMC3578836	['Splenocyte separation and purification\ncd3+ T Cells and Cd11B+ Monocytes were isolated by macs microbeads technology (miltenyi biotec, germany) from the Spleen using negative and positive selection, respectively, according to the manufacturer’s instructions.']	N/A	N/A	[('CL_0000017', 'spermatocyte', 0, 'Splenocyte'), ('CL_0000084', 'T cell', 44, 'T cells'), ('PR_000001309', 'CD70 molecule', 56, 'CD11b'), ('CL_0000576', 'monocyte', 63, 'monocytes'), ('UBERON_0002106', 'spleen', 153, 'spleen')]
PMC3578836	2/2013	S47-PMC3578836	['Nucleic Acid isolation\ntotal rna was isolated from Liver, Splenic T Cells and Monocytes using rneasy mini (qiagen, ca) according to the manufacturer’s instructions.']	N/A	N/A	[('CHEBI_17497', 'glycolic acid', 0, 'Nucleic Acid'), ('GO_0005634', 'nucleus', 0, 'Nucleic'), ('UBERON_0002107', 'liver', 51, 'liver'), ('CL_0000084', 'T cell', 58, 'splenic T cells'), ('UBERON_0002106', 'spleen', 58, 'splenic'), ('CL_0000576', 'monocyte', 78, 'monocytes')]
PMC3578836	2/2013	S49-PMC3578836	['Genomic dna from Livers and T Cells was isolated using the genelute Mammalian Genomic dna miniprep kit (sigma, mo).']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0002107', 'liver', 17, 'livers'), ('CL_0000084', 'T cell', 28, 'T cells'), ('NCBITaxon_33208', 'Metazoa', 68, 'Mammalian'), ('SO_0001026', 'genome', 78, 'Genomic')]
PMC3578836	2/2013	S58-PMC3578836	['four million Resting T Cells were washed 2 times with cold pbs and Lysed by suspending in Lysis buffer as described previously[19].']	N/A	N/A	[('CL_0000748', 'retinal bipolar neuron', 13, 'resting'), ('CL_0000084', 'T cell', 21, 'T cells'), ('GO_0019835', 'cytolysis', 67, 'lysed'), ('GO_0019835', 'cytolysis', 90, 'lysis')]
PMC3578836	2/2013	S69-PMC3578836	['T Cell and Liver Dna Methylation was also quantified with the methylflash methylated dna quantification kit following manufacturer’s instructions (epigentek).']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T cell'), ('UBERON_0002107', 'liver', 11, 'liver'), ('GO_0006306', 'DNA methylation', 17, 'DNA methylation')]
PMC3578836	2/2013	S119-PMC3578836	['ms f1 T Cells are hypermethylated relative to control Mice\nwe quantified T-Cell and Monocytic Dna Methylation with an unbiased, Antibody-based flow cytometric method as shown infigure 3.']	N/A	N/A	[('CL_0000084', 'T cell', 6, 'T cells'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'Mice'), ('CL_0000084', 'T cell', 73, 'T-cell'), ('CL_0000576', 'monocyte', 84, 'monocytic'), ('GO_0006306', 'DNA methylation', 94, 'DNA methylation'), ('GO_0042571', 'immunoglobulin complex, circulating', 128, 'antibody')]
PMC3578836	2/2013	S120-PMC3578836	['dna from Splenic cd3+ T Cells from ms f1 Mice had significantly higher methylation relative to controls at both 17 wk (16%) and 28 wk (20%) of age (figure 3a).']	N/A	N/A	[('UBERON_0002106', 'spleen', 9, 'splenic'), ('CL_0000084', 'T cell', 22, 'T cells'), ('NCBITaxon_10088', 'Mus <genus>', 41, 'mice')]
PMC3578836	2/2013	S127-PMC3578836	['cd3+ T Cells ( a ) or Cd11B+ cells ( b ) isolated from 17 wk or 28 wk old f1 Apoe−/−Mice were stained with anti-Methylcytidine Antibody and subjected to facs analysis.']	N/A	N/A	[('CL_0000084', 'T cell', 5, 'T cells'), ('PR_000001309', 'CD70 molecule', 22, 'CD11b'), ('PR_000004155', 'apolipoprotein E', 77, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'mice'), ('CHEBI_25347', 'methyluridine', 112, 'methylcytidine'), ('GO_0042571', 'immunoglobulin complex, circulating', 127, 'antibody')]
PMC3578836	2/2013	S130-PMC3578836	['17 wk: n\u200a=\u200a7 control and 5 ms Mice; 28 wk: n\u200a=\u200a9 control and 8 ms Mice * p<0.05.10.1371/journal.pone.0056253.g004\n\ncaption (fig): figure 4\nT Cells and Liver from ms f1 Mice are hypermethylated relative to control Mice.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 30, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 66, 'mice'), ('CL_0000084', 'T cell', 139, 'T cells'), ('UBERON_0002107', 'liver', 151, 'Liver'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 213, 'mice')]
PMC3578836	2/2013	S131-PMC3578836	['T Cell ( a ) and Liver ( b ) dna were isolated from 4 wk, 17 wk, 28 wk or 34 wk old f1 Apoe−/−Mice and the level of methylation measured by elisa.']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T cell'), ('UBERON_0002107', 'liver', 17, 'Liver'), ('PR_000004155', 'apolipoprotein E', 87, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 94, 'mice')]
PMC3578836	2/2013	S137-PMC3578836	['we interrogated Ccr2, Ccr5, and cxcr3 mrna Expression in T Cells by qrt-pcr.']	N/A	N/A	[('PR_000005169', 'CMRF35-like molecule 9', 16, 'Ccr2'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 22, 'Ccr5'), ('GO_0010467', 'gene expression', 43, 'expression'), ('CL_0000084', 'T cell', 57, 'T cells')]
PMC3578836	2/2013	S143-PMC3578836	['Splenic cd3+ T Cells and Cd11B+ Cells from f1 Apoe−/−Mice were harvested at the age of 17 wk, 28 wk and 34 wk.']	N/A	N/A	[('CL_0000216', 'Sertoli cell', 0, 'Splenic'), ('UBERON_0002106', 'spleen', 0, 'Splenic'), ('CL_0000084', 'T cell', 13, 'T cells'), ('PR_000001309', 'CD70 molecule', 25, 'CD11b'), ('CL_0000573', 'retinal cone cell', 32, 'cells'), ('PR_000004155', 'apolipoprotein E', 46, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 53, 'mice')]
PMC3578836	2/2013	S144-PMC3578836	['mrna was isolated and Ccr2 levels were measured by qrt-pcr in T Cells ( a ) or Monocytes ( b ).']	N/A	N/A	[('PR_000005169', 'CMRF35-like molecule 9', 22, 'Ccr2'), ('CL_0000084', 'T cell', 62, 'T cells'), ('CL_0000576', 'monocyte', 79, 'monocytes')]
PMC3578836	2/2013	S145-PMC3578836	['c. protein from Apoe−/−Mice at the age of 17 wk, 28 wk, and 34 wk were used to check the level of Ccr2 in cd3+ T Cells.']	N/A	N/A	[('PR_000004155', 'apolipoprotein E', 16, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 23, 'mice'), ('PR_000001204', 'C-C chemokine receptor type 8', 98, 'CCR2'), ('CL_0000084', 'T cell', 111, 'T cells')]
PMC3578836	2/2013	S166-PMC3578836	['we checked a panel of pro-inflammatory cytokines in Serum as well as in Cd4+ T-Cell conditioned media from 17 wk and 28 wk old control and ms f1 Mice.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CL_0000476', 'thyrotroph', 72, 'CD4 ...'), ('CL_0000084', 'T cell', 77, 'T-cell'), ('NCBITaxon_10088', 'Mus <genus>', 145, 'mice')]
PMC3578836	2/2013	S167-PMC3578836	['the T-Cell conditioned media from ms f1 Mice had significantly lower level of Il-17, Tnf-Α and Il-6 relative to control (figure 8).']	N/A	N/A	[('CL_0000084', 'T cell', 4, 'T-cell'), ('GO_0085026', 'tubovesicular membrane network', 4, 'T-cell'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('PR_000001470', 'interleukin-28B', 78, 'IL-17'), ('PR_000000134', 'tumor necrosis factor alpha', 85, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 95, 'IL-6')]
PMC3578836	2/2013	S172-PMC3578836	['cd3+ T Cells were stimulated with cona in the presence of Il-2 for 72 h. the levels of Il-17, Tnf-Α, Il-6 and Il-2 in the conditioned media were measured as described in methods.']	N/A	N/A	[('CL_0000084', 'T cell', 5, 'T cells'), ('PR_000001470', 'interleukin-28B', 58, 'IL-2'), ('PR_000001470', 'interleukin-28B', 87, 'IL-17'), ('PR_000000134', 'tumor necrosis factor alpha', 94, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 101, 'IL-6'), ('PR_000001470', 'interleukin-28B', 110, 'IL-2')]
PMC3578836	2/2013	S261-PMC3578836	['caption (supplementary-material): figure s2\n\neffect of ms diet on Ccr5 and Cxcr3 Expression in f1 T Cells and Monocytes.']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 66, 'CCR5'), ('PR_000001204', 'C-C chemokine receptor type 8', 75, 'CXCR3'), ('GO_0010467', 'gene expression', 81, 'expression'), ('CL_0000084', 'T cell', 98, 'T cells'), ('CL_0000576', 'monocyte', 110, 'monocytes')]
PMC3578836	2/2013	S262-PMC3578836	['Splenic cd3+ T Cells and Cd11B+ Monocytic Cells from f1 Apoe−/− Mice were harvested at the age of 17 wk and 28 wk.']	N/A	N/A	[('UBERON_0002106', 'spleen', 0, 'Splenic'), ('CL_0000084', 'T cell', 13, 'T cells'), ('PR_000001309', 'CD70 molecule', 25, 'CD11b'), ('CL_0002194', 'monopoietic cell', 32, 'monocytic cells'), ('PR_000004155', 'apolipoprotein E', 56, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 64, 'mice')]
PMC3578836	2/2013	S263-PMC3578836	['mrna was isolated and Ccr5, cxcr3 levels were measured by qrt-pcr in T Cells (a) or Monocytes (b).']	N/A	N/A	[('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 22, 'Ccr5'), ('CL_0000084', 'T cell', 69, 'T cells'), ('CL_0000576', 'monocyte', 84, 'monocytes')]
PMC3635901	4/2013	S89-PMC3635901	['in these Tissues, the T Cells are stimulated, after which they Proliferate strongly, acquire migratory properties by rearranging specific Genes and producing targeting chemokines, and can then enter the circulation and induce Cns disease.']	N/A	N/A	[('UBERON_0000479', 'tissue', 9, 'tissues'), ('CL_0000084', 'T cell', 22, 'T cells'), ('GO_0008283', 'cell proliferation', 63, 'proliferate'), ('SO_0000704', 'gene', 138, 'genes'), ('UBERON_0001017', 'central nervous system', 226, 'CNS')]
PMC3728489	7/2013	S34-PMC3728489	['the remaining maternal Decidua is comprised of Macrophages (cd 209+), while T-Cells, Dendritic Cells and specialized B Cells are scarce (chazara et al.,2011; erlebacher,2013).']	N/A	N/A	[('UBERON_0002450', 'decidua', 23, 'decidua'), ('CL_0000235', 'macrophage', 47, 'macrophages'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 63, '209'), ('CL_0000084', 'T cell', 76, 'T-cells'), ('CL_0000451', 'dendritic cell', 85, 'dendritic cells'), ('CL_0000236', 'B cell', 117, 'B cells')]
PMC3728489	7/2013	S67-PMC3728489	['during Thymic Maturation, potential self-reactive T-Cells are deleted by a positive and negative central tolerance process.']	N/A	N/A	[('GO_0043039', 'tRNA aminoacylation', 7, 'thymic maturation'), ('UBERON_0002370', 'thymus', 7, 'thymic'), ('CL_0000084', 'T cell', 50, 'T-cells')]
PMC3728489	7/2013	S68-PMC3728489	['positive tolerance refers to the process by which T-Cells are exposed and bind (via T-Cell receptors) to “self” Mhc Molecules.']	N/A	N/A	[('CL_0000084', 'T cell', 50, 'T-cells'), ('GO_0005618', 'cell wall', 51, '-cells'), ('CL_0000084', 'T cell', 84, 'T-cell'), ('GO_0085026', 'tubovesicular membrane network', 84, 'T-cell'), ('GO_0042611', 'MHC protein complex', 112, 'MHC'), ('CHEBI_36357', 'polyatomic entity', 116, 'molecules')]
PMC3728489	7/2013	S69-PMC3728489	['if T-Cells fail to bind or bind with too high affinity to self-Mhc Molecules, then they are deleted (griesemer et al.,2010).']	N/A	N/A	[('CL_0000084', 'T cell', 3, 'T-cells'), ('GO_0042611', 'MHC protein complex', 63, 'MHC'), ('CHEBI_36357', 'polyatomic entity', 67, 'molecules')]
PMC3728489	7/2013	S71-PMC3728489	['if T-Cells respond to any of these Antigens, they are deleted (blackman et al.,1986).']	N/A	N/A	[('CL_0000084', 'T cell', 3, 'T-cells'), ('CHEBI_59132', 'antigen', 35, 'antigens')]
PMC3728489	7/2013	S72-PMC3728489	['as a result, T-Cells that bind to self-Mhc Molecules in conjunction with a foreign peptide, but do not recognize self-Antigens, are selected.']	N/A	N/A	[('CL_0000084', 'T cell', 13, 'T-cells'), ('GO_0042611', 'MHC protein complex', 39, 'MHC'), ('CHEBI_36357', 'polyatomic entity', 43, 'molecules'), ('CHEBI_59132', 'antigen', 118, 'antigens')]
PMC3728489	7/2013	S77-PMC3728489	['Tregs are generated either at the Thymus by the process of T-Cell Selection, or at the Peripheral Tissue when naïve T-Cells are activated in the presence of specific Immunosuppressive factors (e.g., Transforming Growth Factor (Tgf)-Ss) (chen et al.,2003).']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 0, 'Tregs'), ('UBERON_0002370', 'thymus', 34, 'thymus'), ('CL_0000084', 'T cell', 59, 'T-cell'), ('GO_0045058', 'T cell selection', 59, 'T-cell selection'), ('UBERON_0009132', 'peroneus', 87, 'peripheral tissue'), ('CL_0000084', 'T cell', 116, 'T-cells'), ('CHEBI_48497', 'imidodiphosphate', 166, 'immunosuppressive'), ('PR_000000183', 'TGF-beta 2', 199, 'transforming growth factor ...'), ('PR_000000183', 'TGF-beta 2', 227, 'TGF)-ß')]
PMC3763666	7/2012	S45-PMC3763666	['stimulation of Tlrs by various pamps induces the Differentiation Of T Cells, with Th1 cells that mediates Cellular Responses and inflammatory reactions and Th2 Cells which mediates humoral responses, Antiparasitic Defense and allergic reactions [20].']	N/A	N/A	[('GO_0042462', 'eye photoreceptor cell development', 15, 'TLRs'), ('GO_0030154', 'cell differentiation', 49, 'differentiation of T cells'), ('CL_0000084', 'T cell', 68, 'T cells'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 82, 'Th1'), ('GO_0006915', 'apoptotic process', 106, 'cellular responses'), ('CL_0000546', 'T-helper 2 cell', 156, 'Th2 cells'), ('GO_0010142', 'farnesyl diphosphate biosynthetic process, mevalonate pathway', 200, 'antiparasitic defense')]
PMC3773919	9/2013	S150-PMC3773919	['in addition, T-Cells stimulated by bfdbm bifidum matured Dcs as producers of more Il-10 [78].']	N/A	N/A	[('CL_0000084', 'T cell', 13, 'T-cells'), ('CL_0000990', 'conventional dendritic cell', 57, 'DCs'), ('PR_000001470', 'interleukin-28B', 82, 'IL-10')]
PMC3773919	9/2013	S153-PMC3773919	['these Treg Cells produce increased levels of Il-10 and are capable of inhibiting the Proliferation Of bystander T-Cells.']	N/A	N/A	[('CL_0000960', 'T3 B cell', 6, 'Treg cells'), ('PR_000001470', 'interleukin-28B', 45, 'IL-10'), ('GO_0008283', 'cell proliferation', 85, 'proliferation of ... T ... cells'), ('CL_0000084', 'T cell', 112, 'T-cells')]
PMC3773919	9/2013	S161-PMC3773919	['administration of the Probiotics Mixture induced both T-Cells and B-Cells hyporesponsiveness and downregulated th1, th2, and th17 cytokines [81,83].']	N/A	N/A	[('CHEBI_26346', 'prostaglandins J', 22, 'probiotics'), ('CHEBI_60004', 'mixture', 33, 'mixture'), ('CL_0000084', 'T cell', 54, 'T-cells'), ('CL_0000236', 'B cell', 66, 'B-cells')]
PMC3773919	9/2013	S163-PMC3773919	['conversion of T Cells into Foxp3+ Tregs is directly mediated by Regulatory Dcs that Express high levels of Il-10 and Tgf- Β .']	N/A	N/A	[('CL_0000084', 'T cell', 14, 'T cells'), ('GO_0007567', 'parturition', 16, 'cells'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 27, 'Foxp3'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 34, 'Tregs'), ('CL_0000038', 'erythroid progenitor cell', 64, 'regulatory DCs'), ('GO_0065007', 'biological regulation', 64, 'regulatory'), ('GO_0010467', 'gene expression', 84, 'express'), ('PR_000001470', 'interleukin-28B', 107, 'IL-10'), ('PR_000000046', 'TGF-beta', 117, 'TGF- β')]
PMC3850030	9/2013	S469-PMC3850030	['abbreviations\na-dmrs: chronological age; aeds: Antiepileptic Drugs; afc: antral follicle count; amh: antimullerian hormone; apap: Acetaminophen (Paracetamol); ap-dmrs: age-related phenotypes; ar: Androgen receptor; Bm: Bone Marrow; Bpa: Bisphenol A; ccrk: Cell Cycle-related kinase; cdc: centers for disease control; Cns: Central Nervous System; cpgs: Cytosine-phosphate-guanine; ct: computerized tomography; Cxcr4+: C-x-C Chemokine Receptor Type 4; dmrs: differentially methylated regions; edstac: endocrine disruptor screening and testing advisory committee; facs: fluorescence activated cell sorting; fda: Food and Drug administration; Dha: Docosahexaenoic Acid; dna: Deoxyribonucleic Acid; dsm: diagnostic and statistical manual of mental disorders; Edcs: Endocrine-disrupting chemicals; ets: environmental tobacco smoke; f1-cd: control diet; f1-lpd: low-protein-diet; ffq: Food frequency questionnaire; fmri: functional magnetic resonance imaging; gh/igh: Growth Hormone/Insulin-Like Growth Factor 1; gr: glucocorticoid receptor; Hat: Histone Acetylases; hcc: hepatocellular carcinoma; hdac: Histone deacetylases; hfd: high-fat-diet; hpaa: Hypothalamic-Pituitary-Adrenal axis; Hsc: Hematopoietic Stem Cells; ictp: trimeric carboxyterminal telopeptide; infanib: infant Neurological international battery; iq: intelligence quotient; lbw: low-birthweight; lt-hsc: Long-Term Repopulation Of Hematopoietic Stem Cells; lys: lysine; Mgso4: Magnesium Sulfate; Mirna: micro-Ribonucleic Acid; mri: magnetic resonance imaging; Nac: N-Acetylcysteine; nhanes: national health and nutritional examination survey; nhis: national health interview survey; oc: Osteocalcin; O-Glcnac: O-Glcnacylation; ogtt: oral Glucose tolerance test; or: odds ratio; otc: over the counter; pbdes: polybrominated diphenyl ethers; pcos: polycystic Ovary syndrome; pet: positron emission tomography; pfcs: Perfluorinated Compounds; pp: precocious pubarche; psa: Prostate Specific Antigen; rna: Ribonucleic Acid; rt-pcr: reverse transcriptase polymerase chain reaction; scls: Salivary Cotinine levels; Sdf-1: Stromal-Cell-Derived-Factor-1; ses: socio-economic status; Sirnas: short inhibitory ribonucleic Acids; tcf: T-Cell factor; tcscs: Tissue-committed Stem Cells; tedx: the Endocrine disruption exchange; uspstf: u.s. preventive services task force; Vcam-1: Vascular Cell Adhesion Protein 1.']	N/A	N/A	[('CHEBI_35218', 'anthocyanin cation', 47, 'Antiepileptic drugs'), ('CHEBI_2404', 'acetosyringone', 130, 'Acetaminophen'), ('CHEBI_46195', 'paracetamol', 145, 'paracetamol'), ('CHEBI_50113', 'androgen', 196, 'Androgen'), ('UBERON_0005401', 'cerebral hemisphere gray matter', 215, 'BM'), ('UBERON_0002371', 'bone marrow', 219, 'Bone marrow'), ('CHEBI_34018', '(S)-AMPA', 232, 'BPA'), ('CHEBI_33216', 'bisphenol A', 237, 'Bisphenol A'), ('GO_0007049', 'cell cycle', 256, 'Cell cycle'), ('UBERON_0001017', 'central nervous system', 317, 'CNS'), ('UBERON_0001017', 'central nervous system', 322, 'Central nervous system'), ('CHEBI_4056', 'cytochrome', 352, 'Cytosine'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 409, 'CXCR4'), ('CHEBI_51686', 'haematoxylin', 417, 'C-'), ('PR_000005920', 'lambda-crystallin', 417, 'C-'), ('PR_000001215', 'atypical chemokine receptor 2', 420, '-C chemokine receptor type 4'), ('CHEBI_33290', 'food', 609, 'Food'), ('CHEBI_23888', 'drug', 618, 'Drug'), ('CHEBI_17874', 'dihydrozeatin', 639, 'DHA'), ('CHEBI_78869', 'octacosapentaenoic acid', 644, 'Docosahexaenoic acid'), ('CHEBI_86026', 'tRNA threonylcarbamoyladenosine', 671, 'Deoxyribonucleic acid'), ('CL_0002364', 'cortical thymic epithelial cell', 754, 'EDCs'), ('GO_0009790', 'embryo development', 760, 'Endocrine'), ('CHEBI_33290', 'food', 878, 'Food'), ('CHEBI_5542', 'grayanotoxin I', 961, 'Growth Hormone'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 976, 'Insulin-like growth factor 1'), ('PR_000008443', 'huntingtin-associated protein 1', 1035, 'HAT'), ('CHEBI_15358', 'histone', 1040, 'Histone'), ('PR_000008454', 'hepatitis A virus cellular receptor 2', 1040, 'Histone acetylases'), ('CHEBI_15358', 'histone', 1097, 'Histone'), ('PR_000027594', 'histone H3', 1097, 'Histone'), ('UBERON_0001898', 'hypothalamus', 1145, 'Hypothalamic'), ('UBERON_0002109', 'pair of nares', 1158, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 1168, 'adrenal'), ('CL_0000037', 'hematopoietic stem cell', 1182, 'HSC'), ('CL_0000037', 'hematopoietic stem cell', 1187, 'Hematopoietic stem cells'), ('GO_0030097', 'hemopoiesis', 1187, 'Hematopoietic'), ('UBERON_0001016', 'nervous system', 1273, 'Neurological'), ('GO_0006099', 'tricarboxylic acid cycle', 1366, 'Long-term'), ('GO_0009450', 'gamma-aminobutyric acid catabolic process', 1376, 'repopulation of'), ('CL_0000037', 'hematopoietic stem cell', 1392, 'hematopoietic stem cells'), ('GO_0016476', 'regulation of embryonic cell shape', 1392, 'hematopoietic stem cells'), ('CHEBI_32599', 'magnesium sulfate', 1431, 'MgSO4'), ('CHEBI_31795', 'magnesium sulfate heptahydrate', 1438, 'Magnesium sulfate'), ('SO_0000276', 'miRNA', 1457, 'miRNA'), ('CHEBI_15986', 'polynucleotide', 1470, 'ribonucleic acid'), ('CHEBI_7421', 'NAC', 1521, 'NAC'), ('CHEBI_70981', '6-formylpterin', 1526, 'N-acetylcysteine'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 1648, 'Osteocalcin'), ('CHEBI_63103', 'NSDB 211', 1661, 'O-GlcNAc'), ('CHEBI_52846', 'cycloalkane ring', 1671, 'O-GlcNAcylation'), ('CHEBI_17234', 'glucose', 1699, 'glucose'), ('UBERON_0000992', 'ovary', 1818, 'ovary'), ('CHEBI_86922', 'Pinoresinol biphenyl', 1875, 'Perfluorinated'), ('CHEBI_36357', 'polyatomic entity', 1890, 'compounds'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 1931, 'Prostate specific antigen'), ('CHEBI_59132', 'antigen', 1949, 'antigen'), ('CHEBI_15986', 'polynucleotide', 1963, 'Ribonucleic acid'), ('UBERON_0001836', 'saliva', 2044, 'Salivary'), ('CHEBI_18123', 'N-methylnicotinate', 2053, 'cotinine'), ('PR_000014762', 'serine/arginine-rich splicing factor 5', 2070, 'SDF-1'), ('CL_0000810', 'CD4-positive, alpha-beta thymocyte', 2077, 'Stromal-cell'), ('PR_000015629', 'SRSF protein kinase 1', 2077, 'Stromal-cell-derived-factor-1'), ('UBERON_0003891', 'stroma', 2077, 'Stromal'), ('SO_0000646', 'siRNA', 2136, 'siRNAs'), ('CHEBI_37527', 'acid', 2173, 'acids'), ('CL_0000084', 'T cell', 2185, 'T-cell'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 2207, 'Tissue ...'), ('UBERON_0000479', 'tissue', 2207, 'Tissue'), ('CL_0000034', 'stem cell', 2224, 'stem cells'), ('GO_0009790', 'embryo development', 2246, 'Endocrine'), ('PR_000001970', 'vascular cell adhesion protein 1', 2322, 'VCAM-1'), ('CL_0000635', "Deiter's cell", 2330, 'Vascular cell'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2330, 'Vascular cell adhesion protein 1')]
PMC3877003	12/2013	S105-PMC3877003	['adopting a wider annotation rule allowed us to identify further Immune signatures such as those involving cd4+ T-Cells and innate Immune System.']	N/A	N/A	[('UBERON_0002405', 'immune system', 64, 'immune'), ('CL_0000084', 'T cell', 111, 'T-cells'), ('UBERON_0002405', 'immune system', 130, 'immune system')]
PMC3937977	2/2014	S103-PMC3937977	['the fetal T-Cell (and B-Cell) Development begins at the end of the first trimester, with a rapid expansion of cell numbers through early childhood.']	N/A	N/A	[('CL_0000084', 'T cell', 10, 'T-cell'), ('GO_0042092', 'type 2 immune response', 10, 'T-cell ...'), ('CL_0000236', 'B cell', 22, 'B-cell'), ('GO_0002326', 'B cell lineage commitment', 22, 'B-cell ... development')]
PMC3937977	2/2014	S104-PMC3937977	['this expansion involves the de novo Production and export By the Thymus Of transitional T-Cells (recent Thymic emigrants; rte), which then mature into naïve cells in the periphery.']	N/A	N/A	[('GO_0014010', 'Schwann cell proliferation', 36, 'production ... by ... of ... T-cells'), ('UBERON_0002370', 'thymus', 65, 'thymus'), ('CL_0000084', 'T cell', 88, 'T-cells'), ('UBERON_0002370', 'thymus', 104, 'thymic')]
PMC4106226	7/2014	S40-PMC4106226	['in particular, at the level of the Immune System, 1, 25(Oh)2 D3 prevents the Transformation Of Dendritic Cells Into Antigen presenting Cells, and at the level of the Pancreatic Islets, it decreases proinflammatory chemokine and cytokine Expression (e.g., Il6) resulting in decreased T Cell Recruitment and infiltration, increased Regulatory Cells, and arrest of the Autoimmune process.']	N/A	N/A	[('UBERON_0002405', 'immune system', 35, 'immune system'), ('CHEBI_37958', 'dye', 50, '1,'), ('CHEBI_73394', 'Ala-Ser', 53, '25(OH)2 D3'), ('GO_0006451', 'translational readthrough', 77, 'transformation of ... cells into'), ('CL_0000451', 'dendritic cell', 95, 'dendritic cells'), ('CHEBI_59132', 'antigen', 116, 'antigen'), ('GO_0030154', 'cell differentiation', 116, 'antigen ... cells'), ('CL_0000573', 'retinal cone cell', 135, 'cells'), ('UBERON_0000006', 'islet of Langerhans', 166, 'pancreatic islets'), ('GO_0010467', 'gene expression', 237, 'expression'), ('PR_000008989', 'interleukin-1 family member 7', 255, 'IL6'), ('CL_0000084', 'T cell', 283, 'T cell'), ('GO_0001774', 'microglial cell activation', 283, 'T cell recruitment'), ('CL_0000232', 'erythrocyte', 330, 'regulatory cells'), ('GO_0065007', 'biological regulation', 330, 'regulatory'), ('UBERON_0001442', 'skeleton of manus', 366, 'autoimmune')]
PMC4113768	7/2014	S258-PMC4113768	['advanced multi-colour flow cytometry was used to assess T-Cell Signalling, T Cell Effector Responses, and markers of T-Cell Activation and Homeostasis.']	N/A	N/A	[('CL_0000084', 'T cell', 56, 'T-cell'), ('GO_0007179', 'transforming growth factor beta receptor signaling pathway', 56, 'T-cell signalling'), ('GO_0005854', 'nascent polypeptide-associated complex', 57, '-'), ('CL_0000084', 'T cell', 75, 'T cell'), ('GO_0001783', 'B cell apoptotic process', 75, 'T cell ... responses'), ('CHEBI_35224', 'effector', 82, 'effector'), ('CL_0000084', 'T cell', 117, 'T-cell'), ('GO_0042110', 'T cell activation', 117, 'T-cell activation'), ('GO_0005854', 'nascent polypeptide-associated complex', 118, '-'), ('GO_0042592', 'homeostatic process', 139, 'homeostasis')]
PMC4113768	7/2014	S1586-PMC4113768	['characteristics of participants included in this study: baseline characteristics n = 312*; age, years 34(10); male sex 290 (93%); europid country of birth 222 (71%); Cd4 (cells/µl) 516 (254); Cd4 (% of T-Lymphocytes) 25 (8); Cd4<200 21 (7%); cd4<350 81 (26%); antiretroviral naïve 144 (46%); season of Vitamin D measurement:winter 113 (36%); spring 94 (30%); summer 62 (20%); autumn 43 (14%); Vitamin D (nmol/l) 57 (28); Vitamin D ≥ 75 nmol/l 75 (24%); Vitamin D < 50 nmol/l 142 (45%); Vitamin D < 25 nmol/l 29 (9%); *mean(sd) or n (%).']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 166, 'CD4'), ('PR_000001204', 'C-C chemokine receptor type 8', 192, 'CD4'), ('CL_0000084', 'T cell', 202, 'T-lymphocytes'), ('PR_000001204', 'C-C chemokine receptor type 8', 225, 'CD4'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 393, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 421, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 453, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 486, 'Vitamin D')]
PMC4143239	8/2014	S175-PMC4143239	['Thymus\nthe Thymus Gland is the central Lymphatic Organ in the acquired Immune System, where Maturation and Proliferation Of T-Lymphocytes take place.']	N/A	N/A	[('UBERON_0002370', 'thymus', 0, 'Thymus'), ('UBERON_0002370', 'thymus', 11, 'thymus gland'), ('UBERON_0000069', 'larval stage', 39, 'lymphatic organ'), ('UBERON_0002405', 'immune system', 71, 'immune system'), ('GO_0007617', 'mating behavior', 92, 'maturation ...'), ('GO_0001783', 'B cell apoptotic process', 107, 'proliferation of T ... lymphocytes'), ('CL_0000084', 'T cell', 124, 'T-lymphocytes')]
PMC4143239	8/2014	S176-PMC4143239	['the Thymus is large at Birth and undergoes gradual involution after childhood[159], with diminished output of T-Lymphocytes[160].']	N/A	N/A	[('UBERON_0002370', 'thymus', 4, 'thymus'), ('GO_0007567', 'parturition', 23, 'birth'), ('CL_0000084', 'T cell', 110, 'T-lymphocytes')]
PMC4143239	8/2014	S202-PMC4143239	['T-Lymphocytes in Blood\nnumbers of T-Lymphocytes were described in 29 articles ( table s11 ).']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T-lymphocytes'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CL_0000084', 'T cell', 34, 'T-lymphocytes')]
PMC4143239	8/2014	S209-PMC4143239	['Lymphocyte Response to Pha Stimulation\nin healthy children, incubation of Lymphocytes with Pha results in T-Lymphocytes to Proliferate.']	N/A	N/A	[('CL_0000824', 'mature natural killer cell', 0, 'Lymphocyte'), ('GO_0006974', 'cellular response to DNA damage stimulus', 0, 'Lymphocyte response'), ('CHEBI_34926', 'Pitrazepin', 23, 'PHA'), ('GO_0048866', 'stem cell fate specification', 27, 'stimulation'), ('CL_0000542', 'lymphocyte', 74, 'lymphocytes'), ('CHEBI_34926', 'Pitrazepin', 91, 'PHA'), ('CL_0000084', 'T cell', 106, 'T-lymphocytes'), ('GO_0008283', 'cell proliferation', 123, 'proliferate')]
PMC4143239	8/2014	S220-PMC4143239	['malnourished children were found to have fewer Effector T-Lymphocytes, identified as cells lacking the “naïve” markers Cd62L and Cd28[90], fewer Activated T-Lymphocytes, with the markers Cd69 and/or Cd25[212][222][223], and fewer Memory T-Lymphocytes identified by the marker Cd45Ro+[86].']	N/A	N/A	[('CHEBI_35224', 'effector', 47, 'effector'), ('CL_0000911', 'effector T cell', 47, 'effector T-lymphocytes'), ('PR_000001309', 'CD70 molecule', 119, 'CD62L'), ('PR_000001309', 'CD70 molecule', 129, 'CD28'), ('CL_0002627', 'mature astrocyte', 145, 'activated T'), ('CL_0000542', 'lymphocyte', 157, 'lymphocytes'), ('PR_000001309', 'CD70 molecule', 187, 'CD69'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 199, 'CD25'), ('CL_0000313', 'serous secreting cell', 230, 'memory'), ('GO_0007613', 'memory', 230, 'memory'), ('CL_0000084', 'T cell', 237, 'T-lymphocytes'), ('PR_000005170', 'CD37 molecule', 276, 'CD45RO')]
PMC4161853	8/2014	S27-PMC4161853	['Central Arterioles are surrounded by Periarteriolar Lymphoid Sheaths (Pals) that contain the T Cell zone.']	N/A	N/A	[('UBERON_0011986', 'mucosa of infraorbital sinus', 0, 'Central'), ('UBERON_0001980', 'arteriole', 8, 'arterioles'), ('UBERON_0001179', 'peritoneal cavity', 37, 'periarteriolar'), ('UBERON_0000444', 'lymphoid follicle', 52, 'lymphoid sheaths'), ('UBERON_0001960', 'periarterial lymphatic sheath', 70, 'PALS'), ('CL_0000084', 'T cell', 93, 'T cell')]
PMC4161853	8/2014	S35-PMC4161853	['to accomplish its functions, the Spleen encompasses the following Anatomic subunits (figure\xa01): (1) the White Pulp (Wp), containing T Cell zones (Periarteriolar Lymphoid Sheath (Pals)) and B Cell follicles, where the Adaptive Immune Response takes place; (2) the Marginal Zone (Mz) containing Macrophages, Dendritic Cells (Dcs), Natural Killer T (Nkt) Cells (in Mice), B Cell-Helper Neutrophils (nbh), Innate Lymphoid Cells type 3 (Ilc3), Cd4+T Lymphocytes, mz B Cells and Memory B Cells, where Ti-1 and Ti-2 responses take place; (3) the Perifollicular Zone (Pfz), separating the Mz from the Red Pulp (Rp) and containing Rbcs, Pericapillary Macrophages, nbh,and Ilc3; (4) the rp-containing Macrophages, Dcs, nbh, Plasmablasts, being the place where Rbcs are efficiently filtered from the circulation and where Reticulocytes mature [9,10,13–16].']	N/A	N/A	[('UBERON_0002106', 'spleen', 33, 'spleen'), ('UBERON_0001062', 'anatomical entity', 66, 'anatomic'), ('UBERON_0001959', 'white pulp of spleen', 104, 'white pulp'), ('UBERON_0002828', 'ventral cochlear nucleus', 116, 'WP'), ('CL_0000084', 'T cell', 132, 'T cell'), ('UBERON_0001960', 'periarterial lymphatic sheath', 146, 'periarteriolar lymphoid sheath'), ('UBERON_0001960', 'periarterial lymphatic sheath', 178, 'PALS'), ('CL_0000236', 'B cell', 189, 'B cell'), ('GO_0002250', 'adaptive immune response', 217, 'adaptive immune response'), ('UBERON_0002405', 'immune system', 226, 'immune'), ('UBERON_3010452', 'non-involuting marginal zone', 263, 'marginal zone'), ('UBERON_2005031', 'dorsal longitudinal vein', 278, 'MZ'), ('CL_0000235', 'macrophage', 293, 'macrophages'), ('CL_0000451', 'dendritic cell', 306, 'dendritic cells'), ('CL_0000990', 'conventional dendritic cell', 323, 'DCs'), ('CL_0000623', 'natural killer cell', 329, 'natural killer T ...'), ('CL_0000820', 'B-1a B cell', 347, 'NKT ... cells'), ('NCBITaxon_10088', 'Mus <genus>', 362, 'mice'), ('CL_0000236', 'B cell', 369, 'B cell'), ('CL_0000546', 'T-helper 2 cell', 376, 'helper neutrophils'), ('CL_0002486', 'strial intermediate cell', 402, 'innate lymphoid cells'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 432, 'ILC3'), ('PR_000001204', 'C-C chemokine receptor type 8', 439, 'CD4'), ('CL_0000084', 'T cell', 443, 'T lymphocytes'), ('CL_0000236', 'B cell', 461, 'B cells'), ('CL_0000313', 'serous secreting cell', 473, 'memory'), ('GO_0007613', 'memory', 473, 'memory'), ('CL_0000236', 'B cell', 480, 'B cells'), ('PR_000016499', 'poly [ADP-ribose] polymerase tankyrase-2', 495, 'TI-1'), ('PR_000016499', 'poly [ADP-ribose] polymerase tankyrase-2', 504, 'TI-2'), ('UBERON_0003069', 'otic placode', 539, 'perifollicular zone'), ('UBERON_0009133', 'pleuroperitoneal membrane', 560, 'PFz'), ('UBERON_2005031', 'dorsal longitudinal vein', 581, 'MZ'), ('UBERON_0001250', 'red pulp of spleen', 593, 'red pulp'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 603, 'RP'), ('CL_0000232', 'erythrocyte', 622, 'RBCs'), ('CL_0000474', 'pericardial nephrocyte', 628, 'pericapillary macrophages'), ('UBERON_0018382', 'second instar larva', 628, 'pericapillary'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 663, 'ILC3'), ('CL_0000235', 'macrophage', 691, 'macrophages'), ('CL_0000990', 'conventional dendritic cell', 704, 'DCs'), ('CL_0000058', 'chondroblast', 714, 'plasmablasts'), ('CL_0000232', 'erythrocyte', 750, 'RBCs'), ('CL_0000558', 'reticulocyte', 811, 'reticulocytes')]
PMC4161853	8/2014	S108-PMC4161853	['through the dual binding of Antigens to the bcr and tlr, mz B Cells are promptly activated, undergoing Ig class Switching and somatic hyper-mutation in a T Cell-independent manner.']	N/A	N/A	[('CHEBI_59132', 'antigen', 28, 'antigens'), ('CL_0000236', 'B cell', 60, 'B cells'), ('GO_0071735', 'IgG immunoglobulin complex', 103, 'Ig'), ('GO_0036268', 'swimming', 112, 'switching'), ('CL_0000084', 'T cell', 154, 'T cell')]
PMC4161853	8/2014	S110-PMC4161853	['when only the bcr is stimulated, mz B Cells migrate to the T Cell zone to develop a T Cell-dependent Antibody response.']	N/A	N/A	[('CL_0000236', 'B cell', 36, 'B cells'), ('CL_0000084', 'T cell', 59, 'T cell'), ('CL_0000084', 'T cell', 84, 'T cell'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody')]
PMC4161853	8/2014	S111-PMC4161853	['through taci receptors, mz B Cells receive assistance by the nbhto produce Igm and for class switching from Igm to Igg or Iga in a T Cell-independent manner [16].']	N/A	N/A	[('CL_0000236', 'B cell', 27, 'B cells'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 75, 'IgM'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 108, 'IgM'), ('GO_0071735', 'IgG immunoglobulin complex', 115, 'IgG'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 122, 'IgA'), ('CL_0000084', 'T cell', 131, 'T cell')]
PMC4161853	8/2014	S137-PMC4161853	['additionally, salmonella -specific Antibodies facilitate specific T Cell Responses via augmentation of bacterial uptake and induction of Apoptosis in Macrophages [97].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibodies'), ('CL_0000084', 'T cell', 66, 'T cell'), ('GO_0001783', 'B cell apoptotic process', 66, 'T cell responses'), ('GO_0006915', 'apoptotic process', 137, 'apoptosis'), ('CL_0000235', 'macrophage', 150, 'macrophages')]
PMC4161944	9/2014	S228-PMC4161944	['Birth during the wet season in west africa increases the proportion of T-Cells in the Cd8+ compartment, decreasing the Cd4+:Cd8+ ratio (170,171).']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Birth'), ('CL_0000084', 'T cell', 71, 'T-cells'), ('PR_000005170', 'CD37 molecule', 86, 'CD8'), ('PR_000001204', 'C-C chemokine receptor type 8', 119, 'CD4'), ('PR_000005170', 'CD37 molecule', 124, 'CD8')]
PMC4169551	9/2014	S116-PMC4169551	["correlation between Cd25+Cd4Α+ T Cells and Ifnγ secretion was evaluated using pearson's r-test."]	N/A	N/A	[('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 20, 'CD25'), ('PR_000001200', 'C-C chemokine receptor type 4', 25, 'CD4α'), ('CL_0000084', 'T cell', 31, 'T cells'), ('PR_000008920', 'interferon alpha-7', 43, 'IFNγ')]
PMC4169551	9/2014	S161-PMC4169551	['the proportion of Helper T Cells, Cytotoxic T Cells, double positive T Cells, Natural Killer Cells, Γδ T Cells and Regulatory T Cells was not affected by the dietary treatment.']	N/A	N/A	[('CL_0000912', 'helper T cell', 18, 'helper T cells'), ('CL_0000910', 'cytotoxic T cell', 34, 'cytotoxic T cells'), ('GO_0043066', 'negative regulation of apoptotic process', 34, 'cytotoxic'), ('CL_0000084', 'T cell', 69, 'T cells'), ('CL_0000623', 'natural killer cell', 78, 'natural killer cells'), ('CL_0002062', 'type I pneumocyte', 100, 'γδ T cells'), ('CL_0000815', 'regulatory T cell', 115, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 115, 'regulatory')]
PMC4169551	9/2014	S162-PMC4169551	['the proportion of Activated Cd25+Cd4Α+ T Cells among the Cd4+ Helper T Lymphocytes was significantly higher in the scfos group (86.5±5.6% for scfos and 66.7±4.3% for ctrl; p<0.05).']	N/A	N/A	[('CL_0002627', 'mature astrocyte', 18, 'activated'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 28, 'CD25'), ('PR_000001200', 'C-C chemokine receptor type 4', 33, 'CD4α'), ('CL_0000084', 'T cell', 39, 'T cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 57, 'CD4'), ('CL_0000912', 'helper T cell', 62, 'helper T lymphocytes')]
PMC4169551	9/2014	S196-PMC4169551	['Tgfβ1 cooperates with Cd40 ligand, a tumour necrosis factor (tnf) family member Expressed by Cd4+ T Cells, to trigger iga class-switch dna recombination and generate Antigen-specific Iga+ B Cells[44].']	N/A	N/A	[('PR_000000046', 'TGF-beta', 0, 'TGFβ1'), ('PR_000001309', 'CD70 molecule', 22, 'CD40'), ('GO_0010467', 'gene expression', 80, 'expressed'), ('CL_0000251', 'extramedullary cell', 93, 'CD4'), ('PR_000001204', 'C-C chemokine receptor type 8', 93, 'CD4'), ('CL_0000084', 'T cell', 98, 'T cells'), ('CHEBI_59132', 'antigen', 166, 'antigen'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 183, 'IgA'), ('CL_0000236', 'B cell', 188, 'B cells')]
PMC4169551	9/2014	S225-PMC4169551	['the nature of T Cell-Polarizing signals is determined largely by the type of microbial products[53].']	N/A	N/A	[('CL_0000084', 'T cell', 14, 'T cell'), ('GO_0019492', 'proline salvage', 20, '-polarizing')]
PMC4216020	10/2014	S60-PMC4216020	['Ptpn22 encodes a lymphoid-specific phosphatase which is a negative regulator of T-Cell receptor signal Transduction.']	N/A	N/A	[('PR_000013451', 'tyrosine-protein phosphatase non-receptor type 13', 0, 'PTPN22'), ('CL_0000084', 'T cell', 80, 'T-cell'), ('GO_0085026', 'tubovesicular membrane network', 80, 'T-cell'), ('GO_0007049', 'cell cycle', 82, 'cell'), ('GO_0009293', 'transduction', 103, 'transduction')]
PMC4251419	12/2014	S47-PMC4251419	['after 18 hours, when the Dendritic Cells would have migrated to the draining Nodes, the capacity of these Dendritic Cells to take up, process and present Antigen to co-Cultured T Cells was not modified.']	N/A	N/A	[('CL_0000451', 'dendritic cell', 25, 'dendritic cells'), ('UBERON_0000023', 'wing', 77, 'nodes'), ('CL_0000451', 'dendritic cell', 106, 'dendritic cells'), ('CHEBI_59132', 'antigen', 154, 'antigen'), ('CL_0000010', 'cultured cell', 168, 'cultured'), ('CL_0000084', 'T cell', 177, 'T cells')]
PMC4251419	12/2014	S66-PMC4251419	['cells from Individuals with various Vitamin D-Binding Protein (Vdbp) variants were studied and for Individuals with the strong 25(Oh)D binding variant, the availability of 25(Oh)D to Dendritic Cells was restricted, resulting in less Dendritic Cell-T Cell interaction.']	N/A	N/A	[('NCBITaxon_1', 'root', 11, 'individuals'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 36, 'vitamin D-binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 63, 'VDBP'), ('NCBITaxon_1', 'root', 99, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 127, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 133, 'D'), ('CHEBI_71657', 'versiconol acetate', 172, '25(OH)D'), ('CL_0000451', 'dendritic cell', 183, 'dendritic cells'), ('CL_0000451', 'dendritic cell', 233, 'dendritic cell'), ('GO_0030425', 'dendrite', 233, 'dendritic'), ('CL_0000084', 'T cell', 248, 'T cell')]
PMC4263713	12/2014	S12-PMC4263713	['for instance, Ra promotes the Cd4+T Cell Effector Response via Retinoic Acid Receptor Alpha (Rarα)[3]and Modulates the differentiation of Foxp3+Regulatory T Cells (Tregs) and Th17 Effector T Cells.']	N/A	N/A	[('CHEBI_36927', 'carbon-14 atom', 14, 'RA'), ('CL_0000476', 'thyrotroph', 30, 'CD4 ...'), ('CL_0000084', 'T cell', 34, 'T cell'), ('GO_0006955', 'immune response', 34, 'T cell ... response'), ('CHEBI_35224', 'effector', 41, 'effector'), ('CHEBI_26536', 'retinoic acid', 63, 'retinoic acid'), ('PR_000014377', 'ryanodine receptor 1', 63, 'retinoic acid receptor alpha'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 93, 'RARα'), ('GO_0065007', 'biological regulation', 105, 'modulates'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 138, 'Foxp3'), ('GO_0065007', 'biological regulation', 144, 'regulatory'), ('CL_0000084', 'T cell', 155, 'T cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 164, 'Tregs'), ('CL_0000545', 'T-helper 1 cell', 175, 'Th17'), ('CHEBI_35224', 'effector', 180, 'effector'), ('CL_0000911', 'effector T cell', 180, 'effector T cells')]
PMC4263713	12/2014	S78-PMC4263713	['flow cytometry\nthe monoclonal Antibodies pecy5-anti-Cd45, apc-anti-cd3, pe-anti-Cd4, Fitc-anti-Cd8 and Fitc-anti-Cd25 were used to label the T Lymphocytes, and pecy5-anti-Cd45 and Fitc-anti-Cd45R (bd pharmingen, san diego, ca) were used to label the B Lymphocytes.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 30, 'antibodies'), ('PR_000001309', 'CD70 molecule', 52, 'CD45'), ('PR_000001204', 'C-C chemokine receptor type 8', 80, 'CD4'), ('CHEBI_37926', 'fluorescein isothiocyanate', 85, 'FITC'), ('PR_000005170', 'CD37 molecule', 95, 'CD8'), ('CHEBI_37926', 'fluorescein isothiocyanate', 103, 'FITC'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 113, 'CD25'), ('CL_0000084', 'T cell', 141, 'T lymphocytes'), ('PR_000001309', 'CD70 molecule', 171, 'CD45'), ('CHEBI_37926', 'fluorescein isothiocyanate', 180, 'FITC'), ('PR_000001200', 'C-C chemokine receptor type 4', 190, 'CD45R'), ('CL_0000236', 'B cell', 250, 'B lymphocytes')]
PMC4263713	12/2014	S121-PMC4263713	['Lps challenge led to a further increase in the percentage of Cd4+Cd25+T Lymphocytes in the Rats in the vad, vasp and vas1 groups.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 0, 'LPS'), ('PR_000001204', 'C-C chemokine receptor type 8', 61, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 65, 'CD25'), ('CL_0000084', 'T cell', 70, 'T lymphocytes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 91, 'rats')]
PMC4263713	12/2014	S122-PMC4263713	['the interaction between the va level and Lps challenge did not significantly affect the percentage of Cd4+Cd25+T Cells.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 41, 'LPS'), ('PR_000001204', 'C-C chemokine receptor type 8', 102, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 106, 'CD25'), ('CL_0000084', 'T cell', 111, 'T cells')]
PMC4263713	12/2014	S124-PMC4263713	['the Rats in the combined vas1 group had significantly higher percentages of Cd4+Cd25+T Lymphocytes compared with the Rats in the combined vad group (fig.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 4, 'rats'), ('PR_000001204', 'C-C chemokine receptor type 8', 76, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 80, 'CD25'), ('CL_0000084', 'T cell', 85, 'T lymphocytes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 117, 'rats')]
PMC4263713	12/2014	S129-PMC4263713	['3d), there were no significant differences in the percentage of Cd4+Cd8+T Cells among the Rats in the vad, vasp, vas1, vas2 and vas3 groups (fig.']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 64, 'CD4'), ('CL_0000820', 'B-1a B cell', 68, 'CD8 ...'), ('PR_000005170', 'CD37 molecule', 68, 'CD8'), ('CL_0000084', 'T cell', 72, 'T cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 90, 'rats')]
PMC4263713	12/2014	S134-PMC4263713	['b) the percentage of Cd4+Cd25+T Cells was significantly higher in the Rats in the combined vas1 group compared with the Rats in the combined vad group.']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 21, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 25, 'CD25'), ('CL_0000084', 'T cell', 30, 'T cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 70, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 120, 'rats')]
PMC4263713	12/2014	S135-PMC4263713	['c) the Lps challenge significantly enhanced the number of Cd4+Cd25+T Cells after the five va treatments were combined.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 7, 'LPS'), ('PR_000001204', 'C-C chemokine receptor type 8', 58, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 62, 'CD25'), ('CL_0000084', 'T cell', 67, 'T cells')]
PMC4263713	12/2014	S138-PMC4263713	['f) exposure to Lps significantly reduced the number of Cd4+Cd8+T Lymphocytes after the five va treatments were combined.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 15, 'LPS'), ('PR_000001204', 'C-C chemokine receptor type 8', 55, 'CD4'), ('CL_0000820', 'B-1a B cell', 59, 'CD8 ...'), ('PR_000005170', 'CD37 molecule', 59, 'CD8'), ('CL_0000084', 'T cell', 63, 'T lymphocytes')]
PMC4263713	12/2014	S168-PMC4263713	['c) the effects of Vas and Lps treatment on the percentage of Cd4+Cd25+T Cells in the Pps of the Rats in the five groups.']	N/A	N/A	[('CHEBI_39035', 'TES', 18, 'VAS'), ('CHEBI_16412', 'lipopolysaccharide', 26, 'LPS'), ('PR_000001204', 'C-C chemokine receptor type 8', 61, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 65, 'CD25'), ('CL_0000084', 'T cell', 70, 'T cells'), ('UBERON_0004302', 'proximal phalanx', 85, 'PPs'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 96, 'rats')]
PMC4263713	12/2014	S169-PMC4263713	['d) no differences were found in the percentage of Cd4+Cd25+T Cells between the Rats in the combined vad group and the Rats in the four vas groups.']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 50, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 54, 'CD25'), ('CL_0000084', 'T cell', 59, 'T cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 118, 'rats')]
PMC4263713	12/2014	S224-PMC4263713	['Cd4+Cd25+T Cells are T Lymphocytes that Regulate Immune Activation and maintain Immune Homeostasis.']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 0, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 4, 'CD25'), ('CL_0000084', 'T cell', 9, 'T cells'), ('CL_0000084', 'T cell', 21, 'T lymphocytes'), ('GO_0065007', 'biological regulation', 40, 'regulate'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 49, 'immune activation'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('GO_0055090', 'acylglycerol homeostasis', 80, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 80, 'immune')]
PMC4263713	12/2014	S256-PMC4263713	['ra inhibited the Expansion and Activation Of Tcrγδ+T Cells, which decreased the Regulation Of Th17 Cells[36].']	N/A	N/A	[('GO_0010467', 'gene expression', 17, 'expansion ...'), ('GO_0001775', 'cell activation', 31, 'activation of ... T cells'), ('PR_000016190', 'trichohyalin-like protein 1', 45, 'TCRγδ'), ('CL_0000084', 'T cell', 51, 'T cells'), ('GO_2000351', 'regulation of endothelial cell apoptotic process', 80, 'regulation of Th17 cells'), ('CL_0000899', 'T-helper 17 cell', 94, 'Th17 cells')]
PMC4271720	12/2014	S77-PMC4271720	['the same Cd40L Gene on the Promoter of the x-Chromosome was demethylated in female ra Cd4+ T Cells but was not observed in male ra patients (liao et al., 2012).']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 9, 'CD40L'), ('SO_0000704', 'gene', 15, 'gene'), ('SO_0000167', 'promoter', 27, 'promoter'), ('GO_0000805', 'X chromosome', 44, '-chromosome'), ('CL_0000476', 'thyrotroph', 86, 'CD4 ...'), ('CL_0000084', 'T cell', 91, 'T cells')]
PMC4271720	12/2014	S92-PMC4271720	['next to this, it is the promotion of Dna Demethylation in lupus Cd4+ T Cells that lead to the increased Expression of gadd45a , showing that the environment and epigenetics work closely together to determine the expression of disease in an Individual.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 37, 'DNA demethylation'), ('CL_0000476', 'thyrotroph', 64, 'CD4 ...'), ('CL_0000084', 'T cell', 69, 'T cells'), ('GO_0010467', 'gene expression', 104, 'expression'), ('NCBITaxon_1', 'root', 240, 'individual')]
PMC4271720	12/2014	S175-PMC4271720	['it is characterized by Microvascular dysfunction, progressive fibrosis of skin and/or internal Organs, and Immune abnormalities in Microvascular Endothelial Cells, T Lymphocytes, B Lymphocytes, and Fibroblasts.']	N/A	N/A	[('GO_0005874', 'microtubule', 23, 'microvascular'), ('UBERON_0000062', 'organ', 95, 'organs'), ('UBERON_0002405', 'immune system', 107, 'immune'), ('CL_0000129', 'microglial cell', 131, 'microvascular'), ('CL_0000115', 'endothelial cell', 145, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 145, 'endothelial'), ('CL_0000084', 'T cell', 164, 'T lymphocytes'), ('CL_0000236', 'B cell', 179, 'B lymphocytes'), ('CL_0000057', 'fibroblast', 198, 'fibroblasts')]
PMC4302429	1/2015	S122-PMC4302429	['caption (table-wrap): table 1\n\nsubpopulations of T Cells in Animals Fed a diet containing different amounts of Vitamin D 20\xa0hours after infectionpercentage of all cd45+cellsas-vitdl-vitdh-vitd T Cells (Cd45+cd3+)11.25 (4/23.53)7.5 (1.1/18.50)10.70 (2.75/23.35)Regulatory T Cells (Cd45+Cd4+cd3+Cd25+Foxp3+)0.25 (0.04/0.93)0.05 (0.005/0.17)0.09 (0.015/0.5)Nk Cells (Cd45+Nk1.1Cd3−)2.25 (1.525/3.43)3 (0.95/4.4)1.3 (1.15/1.65)Inflammatory Monocytes (Cd45+Cd11B+ly6chighccr2+)28.90 (26.95/34.75)36.20 (25.9/40.85)27 (18.10/31.20)Monocytes (Cd45+Cd11B+ly6cintccr2−)35.35 (33.3/43.33)42.20 (31.4/47.3)34.40 (25.75/37.85)Granulocytes (Cd45+Cd11B+ly6g+Ccr2−)43.25 (28.85/51.58)26.20 (23/49.95)34.20 (28.60/54.40)\nadata are medians (25th/75th percentiles) determined by forward and side-scatter properties from the whole Brain of Animals (four or five Mice per group) of at least three separate experiments.']	N/A	N/A	[('CL_0000084', 'T cell', 49, 'T cells'), ('NCBITaxon_33208', 'Metazoa', 60, 'animals'), ('GO_0007631', 'feeding behavior', 68, 'fed'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CL_0000084', 'T cell', 193, 'T cells'), ('PR_000001309', 'CD70 molecule', 202, 'CD45'), ('CL_0000232', 'erythrocyte', 260, 'Regulatory T cells'), ('GO_0065007', 'biological regulation', 260, 'Regulatory'), ('PR_000001309', 'CD70 molecule', 280, 'CD45'), ('PR_000001204', 'C-C chemokine receptor type 8', 285, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 293, 'CD25'), ('PR_000017653', 'zinc finger protein ZFPM2', 298, 'FoxP3'), ('CL_0000623', 'natural killer cell', 354, 'NK cells'), ('GO_0005634', 'nucleus', 354, 'NK'), ('PR_000001309', 'CD70 molecule', 364, 'CD45'), ('PR_000011120', 'neurofilament medium polypeptide', 369, 'NK1'), ('PR_000005170', 'CD37 molecule', 373, '1CD3'), ('CL_0000174', 'steroid hormone secreting cell', 423, 'Inflammatory monocytes'), ('PR_000001309', 'CD70 molecule', 447, 'CD45'), ('PR_000001309', 'CD70 molecule', 452, 'CD11b'), ('CL_0000576', 'monocyte', 525, 'Monocytes'), ('PR_000001309', 'CD70 molecule', 536, 'CD45'), ('PR_000001309', 'CD70 molecule', 541, 'CD11b'), ('CL_0002062', 'type I pneumocyte', 614, 'Granulocytes'), ('PR_000001309', 'CD70 molecule', 628, 'CD45'), ('PR_000001309', 'CD70 molecule', 633, 'CD11b'), ('PR_000001204', 'C-C chemokine receptor type 8', 644, 'CCR2'), ('UBERON_0000955', 'brain', 812, 'brain'), ('NCBITaxon_33208', 'Metazoa', 821, 'animals'), ('NCBITaxon_10088', 'Mus <genus>', 843, 'mice')]
PMC4311629	1/2015	S96-PMC4311629	['Interleukin-6 (Il-6), predominantly known as a pro-inflammatory cytokine, is Secreted by Skeletal muscle (pal et al.,2014), helper T Cells, as well as by Wat and Bat (mohamed-ali et al.,1997; cannon et al.,1998).']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 0, 'Interleukin-6'), ('PR_000001470', 'interleukin-28B', 15, 'IL-6'), ('GO_0046903', 'secretion', 77, 'secreted'), ('UBERON_0004288', 'skeleton', 89, 'skeletal'), ('CL_0000084', 'T cell', 131, 'T cells'), ('UBERON_0006337', 'distal early tubule', 154, 'WAT'), ('UBERON_0001348', 'brown adipose tissue', 162, 'BAT')]
PMC4311629	1/2015	S154-PMC4311629	['Tl, T Lymphocytes; Sns, Sympathetic Nervous System.']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 0, 'TL'), ('CL_0000084', 'T cell', 4, 'T lymphocytes'), ('UBERON_0001969', 'blood plasma', 19, 'SNS'), ('UBERON_0000013', 'sympathetic nervous system', 24, 'sympathetic nervous system')]
PMC4329404	10/2014	S27-PMC4329404	['treatment of Murine Cd4+T Cells with Vitamin D promotes Il-10 Gene Expression (21) and protein (22), while treatment of Human Cd4+T Cells with Vitamin D also results in Il-10 secretion (23).']	N/A	N/A	[('NCBITaxon_39107', 'Murinae', 13, 'murine'), ('CL_0000476', 'thyrotroph', 20, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 20, 'CD4'), ('CL_0000084', 'T cell', 24, 'T cells'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 56, 'IL-10'), ('GO_0010467', 'gene expression', 62, 'gene expression'), ('SO_0000704', 'gene', 62, 'gene'), ('NCBITaxon_9606', 'Homo sapiens', 120, 'human'), ('PR_000001204', 'C-C chemokine receptor type 8', 126, 'CD4'), ('CL_0000084', 'T cell', 130, 'T cells'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 169, 'IL-10')]
PMC4329404	10/2014	S88-PMC4329404	['total Cd8+T Cells and Cd4+T Cells remained unchanged across all groups, regardless of dietary status (fig.3a,b).']	N/A	N/A	[('CL_0002532', 'CD16-positive myeloid dendritic cell', 6, 'CD8+'), ('PR_000005170', 'CD37 molecule', 6, 'CD8'), ('CL_0000084', 'T cell', 10, 'T cells'), ('CL_0000782', 'myeloid dendritic cell', 22, 'CD4+'), ('PR_000001204', 'C-C chemokine receptor type 8', 22, 'CD4'), ('CL_0000084', 'T cell', 26, 'T cells')]
PMC4329404	10/2014	S98-PMC4329404	['T-Cell subsets were defined as cd3+Cd8+(a), cd3+Cd4+(b), cd3+Cd4+T1St2+(c) and cd3+Cd4+Il-10+(d).']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 1, '-'), ('PR_000005170', 'CD37 molecule', 35, 'CD8'), ('PR_000001204', 'C-C chemokine receptor type 8', 48, 'CD4'), ('PR_000001204', 'C-C chemokine receptor type 8', 61, 'CD4'), ('PR_000016585', 'tripeptidyl-peptidase 1', 65, 'T1ST2'), ('PR_000001204', 'C-C chemokine receptor type 8', 83, 'CD4'), ('PR_000001470', 'interleukin-28B', 87, 'IL-10')]
PMC4354412	3/2015	S163-PMC4354412	['caption (fig): figure 6\n\npercentages of Cd4+Cd25Med T Cells from total Lymphocytes in the il Mln of the Piglets on day 12 in relation to the cd14 value of the attendant sow Milk measured on day 17 of Lactation .']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 40, 'CD4'), ('PR_000005174', 'CD5 molecule-like', 44, 'CD25med'), ('CL_0000084', 'T cell', 52, 'T cells'), ('CL_0000542', 'lymphocyte', 71, 'lymphocytes'), ('UBERON_0001463', 'manual digit 1', 93, 'MLN'), ('NCBITaxon_33208', 'Metazoa', 104, 'piglets'), ('UBERON_0001913', 'milk', 173, 'milk'), ('GO_0007595', 'lactation', 200, 'lactation')]
PMC4372177	2/2015	S264-PMC4372177	['this method estimated the proportions of six cell types (Monocytes, Granulocytes, Cd8+ T-Cells, Cd4+ T-Cells, Nk Cells, and B Cells) for each Individual based on their Genome-wide methylation signatures, using an external reference inferred from sample profiles of cell-specific methylation [125].']	N/A	N/A	[('CL_0000576', 'monocyte', 57, 'monocytes'), ('CL_0000094', 'granulocyte', 68, 'granulocytes'), ('PR_000005170', 'CD37 molecule', 82, 'CD8'), ('CL_0000084', 'T cell', 87, 'T-cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 96, 'CD4'), ('CL_0000084', 'T cell', 101, 'T-cells'), ('CL_0000623', 'natural killer cell', 110, 'NK cells'), ('CL_0000236', 'B cell', 124, 'B cells'), ('NCBITaxon_1', 'root', 142, 'individual'), ('SO_0001026', 'genome', 168, 'genome')]
PMC4425955	4/2015	S190-PMC4425955	['the cd3 Antigen is a marker of T Cells, which are responsible for the Cell-Mediated Immunity (mazairac and joles2010).']	N/A	N/A	[('CHEBI_59132', 'antigen', 8, 'antigen'), ('CL_0000084', 'T cell', 31, 'T cells'), ('GO_0098758', 'response to interleukin-8', 70, 'cell-mediated immunity')]
PMC4448820	5/2015	S229-PMC4448820	['for example, the Foxp3 protein, the master Regulatory transcription factor in determining Treg differentiation, is transiently induced upon Human, but not Mouse, T Cell Activation (137).']	N/A	N/A	[('PR_000017653', 'zinc finger protein ZFPM2', 17, 'FoxP3'), ('GO_0065007', 'biological regulation', 43, 'regulatory'), ('CL_0000901', 'Tr1 cell', 90, 'Treg'), ('NCBITaxon_9606', 'Homo sapiens', 140, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 155, 'mouse'), ('CL_0000084', 'T cell', 162, 'T cell'), ('GO_0042110', 'T cell activation', 162, 'T cell activation')]
PMC4448820	5/2015	S253-PMC4448820	['● Cd8+T Cell function is the least studied of the major components of Acquired Immunity.']	N/A	N/A	[('CL_0002532', 'CD16-positive myeloid dendritic cell', 2, 'CD8+'), ('CL_0000084', 'T cell', 6, 'T cell'), ('GO_0019624', 'atrazine catabolic process to isopropylamine', 70, 'acquired immunity')]
PMC4448820	5/2015	S335-PMC4448820	['factors that Control T Cell Development such as Il-2 are Regulated via Promoter demethylation in T Cells (202).']	N/A	N/A	[('GO_0065007', 'biological regulation', 13, 'control'), ('CL_0000084', 'T cell', 21, 'T cell'), ('GO_0002296', 'T-helper 1 cell lineage commitment', 21, 'T cell development'), ('PR_000001470', 'interleukin-28B', 48, 'IL-2'), ('GO_0065007', 'biological regulation', 57, 'regulated'), ('SO_0000167', 'promoter', 71, 'promoter'), ('CL_0000084', 'T cell', 97, 'T cells')]
PMC4448820	5/2015	S336-PMC4448820	['naive cd4+T Cells differentiate into specific and stable T-Helper (Th) Cell phenotypes (including, but not limited to, th1, th2, th17, and Tregs).']	N/A	N/A	[('CL_0000084', 'T cell', 10, 'T cells'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 57, 'T ... helper ...'), ('CL_0000545', 'T-helper 1 cell', 67, 'Th ... cell'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 139, 'Tregs')]
PMC4448820	5/2015	S678-PMC4448820	['id inhibits the Proliferation Of T Lymphocytes and, to a lesser extent, B Lymphocytes (359).']	N/A	N/A	[('GO_0001783', 'B cell apoptotic process', 16, 'proliferation of T lymphocytes'), ('CL_0000084', 'T cell', 33, 'T lymphocytes'), ('CL_0000236', 'B cell', 72, 'B lymphocytes'), ('GO_0040011', 'locomotion', 74, 'lymphocytes')]
PMC4448820	5/2015	S953-PMC4448820	['● Lamina Propria T Cell subpopulations (cd3, Cd4, and Cd8) are higher than normal, but Cd8:Cd4 values are normal.']	N/A	N/A	[('UBERON_0000030', 'lamina propria', 2, 'Lamina propria'), ('CL_0000084', 'T cell', 17, 'T cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 45, 'CD4'), ('PR_000005170', 'CD37 molecule', 54, 'CD8'), ('PR_000005170', 'CD37 molecule', 87, 'CD8'), ('PR_000001204', 'C-C chemokine receptor type 8', 91, 'CD4')]
PMC4514967	12/2014	S73-PMC4514967	['ra also Modulates the function and phenotype of both Cd4+and Cd8+T Cells, promoting Expression of Ccr9 and α4β7and enhancing Gut homing function.54,57,58in addition, ra helps shape Helper T Cell Differentiation in several ways.']	N/A	N/A	[('GO_0065007', 'biological regulation', 8, 'modulates'), ('PR_000001204', 'C-C chemokine receptor type 8', 53, 'CD4'), ('CL_0000820', 'B-1a B cell', 61, 'CD8 ...'), ('PR_000005170', 'CD37 molecule', 61, 'CD8'), ('CL_0000084', 'T cell', 65, 'T cells'), ('GO_0010467', 'gene expression', 84, 'expression'), ('PR_000001204', 'C-C chemokine receptor type 8', 98, 'CCR9'), ('UBERON_0001555', 'digestive tract', 125, 'gut'), ('CL_0000912', 'helper T cell', 181, 'helper T cell'), ('GO_0030217', 'T cell differentiation', 188, 'T cell differentiation')]
PMC4588865	8/2015	S67-PMC4588865	['cell-type proportions were estimated using the estimatecellcounts function in the minfi r package,35which is based on the method developed by houseman.36this estimated the proportion of B Cells, cd8 T Cells, cd4 Tcells, Granulocytes, Nk Cells and Monocytes in each sample.']	N/A	N/A	[('CL_0000236', 'B cell', 186, 'B cells'), ('CL_0000084', 'T cell', 199, 'T cells'), ('CL_0000084', 'T cell', 212, 'Tcells'), ('CL_0000094', 'granulocyte', 220, 'granulocytes'), ('CL_0000623', 'natural killer cell', 234, 'NK cells'), ('GO_0005634', 'nucleus', 234, 'NK'), ('CL_0000576', 'monocyte', 247, 'monocytes')]
PMC4661500	11/2014	S502-PMC4661500	['the fine tuning of T-Cell function and energetics has been summarized by pearce et al.']	N/A	N/A	[('CL_0000084', 'T cell', 19, 'T-cell'), ('GO_0005622', 'intracellular anatomical structure', 20, '-cell')]
PMC4685088	12/2015	S32-PMC4685088	['upon Activation, the T Cells shed their Surface Cd62L Molecules.']	N/A	N/A	[('GO_0045148', 'tripeptide aminopeptidase activity', 5, 'activation'), ('CL_0000084', 'T cell', 21, 'T cells'), ('GO_0009986', 'cell surface', 40, 'surface'), ('PR_000001309', 'CD70 molecule', 48, 'CD62L'), ('CHEBI_36357', 'polyatomic entity', 54, 'molecules')]
PMC4685088	12/2015	S34-PMC4685088	['Cd54 (Intercellular Adhesion Molecule-1 or Icam-1) is an adhesion Molecule that mediates a co-stimulatory signal in T Cell Activation.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 0, 'CD54'), ('PR_000002051', 'interferon regulatory factor 9', 6, 'intercellular adhesion molecule-1'), ('GO_0030424', 'axon', 20, 'adhesion'), ('CHEBI_36357', 'polyatomic entity', 29, 'molecule'), ('PR_000001367', 'interleukin-12 receptor subunit beta-1', 43, 'ICAM-1'), ('CHEBI_36357', 'polyatomic entity', 66, 'molecule'), ('CL_0000084', 'T cell', 116, 'T cell'), ('GO_0042110', 'T cell activation', 116, 'T cell activation')]
PMC4685088	12/2015	S50-PMC4685088	['with histological Chorioamnionitis, there is infiltration of Polymorphonuclear Leukocytes and other Inflammatory Cells like Macrophages and T Cells as seen microscopically (35–37).']	N/A	N/A	[('UBERON_0003217', 'neural lobe of neurohypophysis', 18, 'chorioamnionitis'), ('CL_0000094', 'granulocyte', 61, 'polymorphonuclear leukocytes'), ('CL_0000902', 'induced T-regulatory cell', 100, 'inflammatory cells'), ('CL_0000235', 'macrophage', 124, 'macrophages'), ('CL_0000084', 'T cell', 140, 'T cells')]
PMC4691762	12/2015	S115-PMC4691762	['the Vitamin D receptor is widely Expressed in the Immune System including T Cells.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0010467', 'gene expression', 33, 'expressed'), ('UBERON_0002405', 'immune system', 50, 'immune system'), ('CL_0000084', 'T cell', 74, 'T cells')]
PMC4703068	8/2015	S140-PMC4703068	['Mice harboring Human microbiota had low levels of Mucosal Cd4+and Cd8+T Cells, few Dendritic Cells and reduced Antimicrobial peptide Expression.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('NCBITaxon_9606', 'Homo sapiens', 15, 'human'), ('CL_0000187', 'muscle cell', 50, 'mucosal ...'), ('UBERON_0000344', 'mucosa', 50, 'mucosal'), ('PR_000001204', 'C-C chemokine receptor type 8', 58, 'CD4'), ('PR_000005170', 'CD37 molecule', 66, 'CD8'), ('CL_0000084', 'T cell', 70, 'T cells'), ('CL_0000451', 'dendritic cell', 83, 'dendritic cells'), ('GO_0030425', 'dendrite', 83, 'dendritic'), ('CHEBI_65381', 'albizoside C', 111, 'antimicrobial'), ('GO_0010467', 'gene expression', 133, 'expression')]
PMC4703068	8/2015	S266-PMC4703068	['like T Cells, ilcs develop from common lymphoid precursors; however, they are not selected for Antigen specificity and do not Express Antigen receptors.']	N/A	N/A	[('CL_0000084', 'T cell', 5, 'T cells'), ('CHEBI_59132', 'antigen', 95, 'antigen'), ('GO_0010467', 'gene expression', 126, 'express'), ('CHEBI_59132', 'antigen', 134, 'antigen')]
PMC4800340	5/2016	S47-PMC4800340	['in the healthnuts study by martino, et al.71dna methylation profiles in cd4+ T-Cells were examined in 24 infants with and without Ige-mediated Food allergy diagnosed at 12 months.']	N/A	N/A	[('CL_0000084', 'T cell', 77, 'T-cells'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 130, 'IgE'), ('CHEBI_33290', 'food', 143, 'food')]
PMC4829879	2/2016	S106-PMC4829879	['luminex xmap technology (luminex, austin, tx) was used for multiplex quantification of the following 24 cytokines and chemokines that were simultaneously measured using a milliplex map Rat cytokine/chemokine panel (millipore, billerica, ma) according to manufacturer specifications: Eotaxin, Granulocyte Colony-Stimulating Factor, Granulocyte Macrophage Colony-Stimulating factor, growth-Related Oncogene/Keratinocyte derived chemokine, Interferon-Γ, Il-10, Il-12 (P70), Il-13, il-17, Il-18, Il-1Α, Il-1Β, Il-2, Il-4, Il-5, Il-6, Il-9, Interferon-Γ–Induced Protein-10, leptin, Mcp-1, Macrophage Inflammatory Protein-1Α, Regulated on activation normal T Cell Expressed and Secreted, Tumor Necrosis Factor-Α, and Vascular Endothelial Growth Factor.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 185, 'rat'), ('PR_000007209', 'steroid hormone receptor ERR2', 283, 'eotaxin'), ('CL_0000094', 'granulocyte', 292, 'granulocyte'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 292, 'granulocyte colony-stimulating factor'), ('CL_0000094', 'granulocyte', 331, 'granulocyte macrophage'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 331, 'granulocyte macrophage colony-stimulating'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 388, 'related'), ('SO_0000895', 'silenced_by_DNA_methylation', 396, 'oncogene'), ('CL_0000312', 'keratinocyte', 405, 'keratinocyte'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 437, 'interferon-γ'), ('PR_000001470', 'interleukin-28B', 451, 'IL-10'), ('PR_000001470', 'interleukin-28B', 458, 'IL-12'), ('PR_000001245', 'rhodopsin', 465, 'p70'), ('PR_000001470', 'interleukin-28B', 471, 'IL-13'), ('PR_000007070', 'homeobox protein engrailed-1', 481, '17'), ('PR_000001470', 'interleukin-28B', 485, 'IL-18'), ('PR_000001388', 'interleukin-32', 492, 'IL-1α'), ('PR_000001383', 'interleukin-22', 499, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 506, 'IL-2'), ('PR_000001470', 'interleukin-28B', 512, 'IL-4'), ('PR_000001470', 'interleukin-28B', 518, 'IL-5'), ('PR_000001470', 'interleukin-28B', 524, 'IL-6'), ('PR_000001470', 'interleukin-28B', 530, 'IL-9'), ('PR_000009130', 'integrin alpha-5', 536, 'interferon-γ–induced protein-10'), ('PR_000010439', 'myeloid leukemia factor 1', 577, 'MCP-1'), ('CL_0000235', 'macrophage', 584, 'macrophage'), ('PR_000010064', 'melanoma-associated antigen B1', 584, 'macrophage inflammatory protein-1α'), ('GO_0065007', 'biological regulation', 620, 'regulated'), ('CL_0000084', 'T cell', 651, 'T cell'), ('GO_0010467', 'gene expression', 658, 'expressed'), ('GO_0046903', 'secretion', 672, 'secreted'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 682, 'tumor necrosis factor-α'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 711, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 720, 'endothelial')]
PMC4829940	5/2016	S66-PMC4829940	['in the primary analysis, the models were adjusted for maternal pre-Pregnancy body mass index (bmi, continuous), offspring sex, maternal education (4 categories), maternal smoking (yes/no), maternal Folate Plasma values (continuous), parity (3 categories), maternal age (continuous), Birth season (four categories) and estimated cell type proportions (continuous matrix consisting of 6 (default) Blood Cell-types: Cd4+T Cells, Cd8+T Cells, Nk-Cells, B-Cells, Monocytes and Granulocytes).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 198, 'folate'), ('UBERON_0001969', 'blood plasma', 205, 'plasma'), ('GO_0007567', 'parturition', 283, 'birth'), ('CL_0000081', 'blood cell', 395, 'blood cell'), ('UBERON_0000178', 'blood', 395, 'blood'), ('CL_0000476', 'thyrotroph', 413, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 413, 'CD4'), ('CL_0000084', 'T cell', 417, 'T cells'), ('CL_0002038', 'T follicular helper cell', 426, 'CD8'), ('PR_000005170', 'CD37 molecule', 426, 'CD8'), ('CL_0000084', 'T cell', 430, 'T cells'), ('CL_0000623', 'natural killer cell', 439, 'NK-cells'), ('GO_0071561', 'nucleus-vacuole junction', 439, 'NK-'), ('CL_0000236', 'B cell', 449, 'B-cells'), ('CL_0000576', 'monocyte', 458, 'monocytes'), ('CL_0000094', 'granulocyte', 472, 'granulocytes')]
PMC4864049	1/2016	S314-PMC4864049	['this includes findings of Neuroinflammation, presence of Autoantibodies, increased T-Cell Responses, increased Natural Killer Cell responses and Monocyte responses in asd subjects\xa0[138].']	N/A	N/A	[('GO_0007009', 'plasma membrane organization', 26, 'neuroinflammation'), ('GO_0044308', 'axonal spine', 57, 'autoantibodies'), ('CL_0000084', 'T cell', 83, 'T-cell'), ('GO_0001914', 'regulation of T cell mediated cytotoxicity', 83, 'T-cell responses'), ('CL_0000623', 'natural killer cell', 111, 'natural killer cell'), ('CL_0000576', 'monocyte', 145, 'monocyte')]
PMC4896250	4/2016	S1185-PMC4896250	['methods : Trpv1 Expression was measured in Cd4+T Cell and cytokine analysis and T Cell Receptor Signaling Pathways were evaluated in bctc pretreated T Cell lines and Trpv1(-/-)T Cells.']	N/A	N/A	[('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 10, 'TRPV1'), ('GO_0010467', 'gene expression', 16, 'expression'), ('CL_0000251', 'extramedullary cell', 43, 'CD4'), ('CL_0000084', 'T cell', 47, 'T cell'), ('CL_0000084', 'T cell', 80, 'T cell'), ('GO_0035507', 'regulation of myosin-light-chain-phosphatase activity', 80, 'T cell receptor signaling pathways'), ('CL_0000084', 'T cell', 149, 'T cell'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 166, 'TRPV1'), ('CL_0000084', 'T cell', 176, 'T cells')]
PMC4896250	4/2016	S1188-PMC4896250	['results: Trpv1 Expression was localized in Cd4+T Cell.']	N/A	N/A	[('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 9, 'TRPV1'), ('GO_0010467', 'gene expression', 15, 'expression'), ('CL_0000251', 'extramedullary cell', 43, 'CD4'), ('CL_0000084', 'T cell', 47, 'T cell')]
PMC4896250	4/2016	S1189-PMC4896250	['Bctc pretreatment and Trpv1 knockout suppressed T Cell Cytokine Production and suppressed T Cell Receptor Signaling Pathways, including Nf-Kb, map kinase and Nfat Signaling in both Jurkat Cell line and cd4 + T Cells in vitro .']	N/A	N/A	[('CHEBI_75508', '5-bromo-4-chloro-3-indolyl phosphate', 0, 'BCTC'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 22, 'TRPV1'), ('CL_0000084', 'T cell', 48, 'T cell'), ('GO_0002369', 'T cell cytokine production', 48, 'T cell cytokine production'), ('CL_0000084', 'T cell', 90, 'T cell'), ('GO_0035507', 'regulation of myosin-light-chain-phosphatase activity', 90, 'T cell receptor signaling pathways'), ('GO_0071159', 'NF-kappaB complex', 136, 'NF-kB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 136, 'NF-kB'), ('GO_0038061', 'NIK/NF-kappaB signaling', 158, 'NFAT signaling'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 158, 'NFAT'), ('CL_0000255', 'eukaryotic cell', 181, 'Jurkat cell'), ('CL_0000084', 'T cell', 208, 'T cells')]
PMC4896250	4/2016	S1497-PMC4896250	['methods: the effect of T-Mscs was evaluated in 32 balb/c Mice that were randomly divided into 4 groups (negative control group; Nasal polyp group; t-Msc group and t-Msc(ad) group(t-Msc incubated with Adipogenic differentiated medium)).']	N/A	N/A	[('CL_0000084', 'T cell', 23, 'T-'), ('CL_0000186', 'myofibroblast cell', 25, 'MSCs'), ('NCBITaxon_10088', 'Mus <genus>', 57, 'mice'), ('UBERON_0000004', 'nose', 128, 'nasal'), ('CL_0000186', 'myofibroblast cell', 149, 'MSC'), ('CL_0000186', 'myofibroblast cell', 165, 'MSC'), ('CL_0000186', 'myofibroblast cell', 181, 'MSC'), ('GO_0060612', 'adipose tissue development', 200, 'adipogenic')]
PMC4896250	4/2016	S1498-PMC4896250	['after induction of ova- induced erswnp model, T-Mscs were administered intravenously (T-Msc and T-Msc(ad) groups) on weeks5 to 12 (one time per week)and subsequent ova+seb (three times per week in ova and one time per week in seb) challenge was conducted until 12 weeks.']	N/A	N/A	[('CL_0000084', 'T cell', 46, 'T-MSCs'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 86, 'T'), ('CL_0000186', 'myofibroblast cell', 88, 'MSC'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 96, 'T'), ('CL_0000186', 'myofibroblast cell', 98, 'MSC')]
PMC4896250	4/2016	S1500-PMC4896250	['results: intravenous injection of T-Mscs significantly reduced allergic symptoms, Eosinophil, Neutrophil, Nasal polyp count and Serum ova specific-Igg1 levels.']	N/A	N/A	[('CL_0000084', 'T cell', 34, 'T-MSCs'), ('CL_0000771', 'eosinophil', 82, 'eosinophil'), ('CL_0000775', 'neutrophil', 94, 'neutrophil'), ('UBERON_0000004', 'nose', 106, 'nasal'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 147, 'IgG1')]
PMC4896250	4/2016	S2460-PMC4896250	['subsequently, Drug-specific T-Cell clones were generated by serial dilutions.']	N/A	N/A	[('CHEBI_23888', 'drug', 14, 'drug'), ('CL_0000084', 'T cell', 28, 'T-cell')]
PMC4896250	4/2016	S2462-PMC4896250	['Isoniazid/Rifampicin- specific T-Cell clones were generated from Blood of the patients, but not Pyrazinamide or Ethambutol.']	N/A	N/A	[('CHEBI_6011', 'isoficine', 0, 'Isoniazid'), ('CHEBI_17015', 'riboflavin', 10, 'rifampicin'), ('CL_0000084', 'T cell', 31, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 32, '-'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CHEBI_45285', 'pyrazinecarboxamide', 96, 'pyrazinamide'), ('CHEBI_4877', 'ethambutol', 112, 'ethambutol')]
PMC4896250	4/2016	S2463-PMC4896250	['the T Cell clones Proliferated and Secreted Ifnγ when stimulated with Isoniazid or Rifampicin.']	N/A	N/A	[('CL_0000084', 'T cell', 4, 'T cell'), ('GO_0008283', 'cell proliferation', 18, 'proliferated'), ('GO_0046903', 'secretion', 35, 'secreted'), ('PR_000008920', 'interferon alpha-7', 44, 'IFNγ'), ('CHEBI_63438', 'hexaric acid derivative', 70, 'isoniazid'), ('CHEBI_17015', 'riboflavin', 83, 'rifampicin')]
PMC4896250	4/2016	S2465-PMC4896250	['conclusion: these studies identify Isoniazid/Rifampicin- specific T-Cells in Peripheral Blood of certain patients with atd-induced dress.']	N/A	N/A	[('CHEBI_63438', 'hexaric acid derivative', 35, 'isoniazid'), ('CHEBI_17015', 'riboflavin', 45, 'rifampicin'), ('CL_0000084', 'T cell', 66, 'T-cells'), ('UBERON_0012101', 'perinatal stage', 77, 'peripheral blood')]
PMC4896250	4/2016	S2930-PMC4896250	['we sorted Cd4+T Cells into yfp+and yfp- groups and activated them with anti-cd3/Cd28.']	N/A	N/A	[('CL_0000782', 'myeloid dendritic cell', 10, 'CD4+'), ('PR_000001204', 'C-C chemokine receptor type 8', 10, 'CD4'), ('CL_0000084', 'T cell', 14, 'T cells'), ('PR_000001309', 'CD70 molecule', 80, 'CD28')]
PMC4896250	4/2016	S2933-PMC4896250	['Hur ko T Cells had defects in Proliferation and Jak-Stat Signaling with reduced p-Stat5 and were unable to up-regulate Cd25.']	N/A	N/A	[('PR_000008840', 'huntingtin', 0, 'HuR'), ('CL_0000084', 'T cell', 7, 'T cells'), ('GO_0008283', 'cell proliferation', 30, 'proliferation'), ('GO_0007214', 'gamma-aminobutyric acid signaling pathway', 48, 'JAK-STAT signaling'), ('PR_000015166', 'sodium/glucose cotransporter 5', 48, 'JAK-STAT'), ('PR_000000364', 'smad2', 82, 'stat5'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 119, 'CD25')]
PMC4896250	4/2016	S2943-PMC4896250	['furthermore, Hur ko in T Cells completely abrogates Allergen induced Lung inflammation.']	N/A	N/A	[('PR_000008840', 'huntingtin', 13, 'HuR'), ('CL_0000084', 'T cell', 23, 'T cells'), ('CHEBI_50904', 'allergen', 52, 'allergen'), ('UBERON_0002048', 'lung', 69, 'lung')]
PMC4896250	4/2016	S3327-PMC4896250	['the effect of T-Mscs was evaluated in 24 balb/c Mice that were randomly divided into 4 groups (negative control group; positive control group; t-Msc group and asc group).']	N/A	N/A	[('CL_0000084', 'T cell', 14, 'T-'), ('CL_0000186', 'myofibroblast cell', 16, 'MSCs'), ('NCBITaxon_10088', 'Mus <genus>', 48, 'mice'), ('CL_0000186', 'myofibroblast cell', 145, 'MSC')]
PMC4896250	4/2016	S5049-PMC4896250	['cell suspension was stained with Fluorophore labeled Antibodies to determine Il-33 Intracellular Expression in Cd45+3+T Cells, Cd45+19+B Cells, Cd45+cd3-Cd19-ly-6G-cells, Cd45-324+Epithelial Cells by flow cytometry.']	N/A	N/A	[('CHEBI_51217', 'fluorochrome', 33, 'fluorophore'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('PR_000001470', 'interleukin-28B', 77, 'IL-33'), ('GO_0005622', 'intracellular anatomical structure', 83, 'intracellular'), ('GO_0010467', 'gene expression', 97, 'expression'), ('PR_000001309', 'CD70 molecule', 111, 'CD45'), ('CL_0000084', 'T cell', 118, 'T cells'), ('PR_000001309', 'CD70 molecule', 127, 'CD45'), ('CL_0000236', 'B cell', 135, 'B cells'), ('PR_000001309', 'CD70 molecule', 144, 'CD45'), ('PR_000001309', 'CD70 molecule', 153, 'CD19'), ('PR_000007090', 'glycerophosphocholine cholinephosphodiesterase ENPP6', 161, '6G'), ('PR_000001309', 'CD70 molecule', 171, 'CD45'), ('CL_0000066', 'epithelial cell', 180, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 180, 'epithelial')]
PMC4896250	4/2016	S5779-PMC4896250	['methods: we used cd4cre-Loxp system to delete Smad4 in T Cell-specific manner ( cd4cre ; Smad4Fl/fl,+/+).']	N/A	N/A	[('SO_0000346', 'loxP_site', 24, 'loxp'), ('PR_000000364', 'smad2', 46, 'Smad4'), ('CL_0000084', 'T cell', 55, 'T cell'), ('PR_000000364', 'smad2', 89, 'Smad4fl')]
PMC4896250	4/2016	S5783-PMC4896250	['Smad4 in combination with Smad3 suppressed the Expression of a t-box transcription factor, Eomesodermin (Eomes) in cd8+T Cells.']	N/A	N/A	[('PR_000000364', 'smad2', 0, 'Smad4'), ('PR_000000364', 'smad2', 26, 'Smad3'), ('GO_0010467', 'gene expression', 47, 'expression'), ('PR_000007122', 'ephrin type-A receptor 2', 91, 'Eomesodermin'), ('PR_000007007', 'eukaryotic translation initiation factor 6', 105, 'Eomes'), ('CL_0000084', 'T cell', 119, 'T cells')]
PMC4896250	4/2016	S5784-PMC4896250	['Expression of Eomes and the cytotoxic Molecules in Cd8+T Cells at the early phase of sensitization was significantly upregulated in cd4cre ; Smad4Fl/flmice compared with control cd4cre ; Smad4+/+Mice.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007007', 'eukaryotic translation initiation factor 6', 14, 'Eomes'), ('CHEBI_36357', 'polyatomic entity', 38, 'molecules'), ('CL_0000820', 'B-1a B cell', 51, 'CD8 ...'), ('CL_0000084', 'T cell', 55, 'T cells'), ('PR_000000364', 'smad2', 141, 'Smad4fl'), ('PR_000000364', 'smad2', 187, 'Smad4'), ('NCBITaxon_10088', 'Mus <genus>', 195, 'mice')]
PMC4896250	4/2016	S5785-PMC4896250	['Cytolytic Molecules in Cd8+T Cells upregulated by Smad4 deletion induced th1 Cell Apoptosis, which resulted in increased th2.']	N/A	N/A	[('GO_0012501', 'programmed cell death', 0, 'Cytolytic'), ('CHEBI_36357', 'polyatomic entity', 10, 'molecules'), ('PR_000005170', 'CD37 molecule', 23, 'CD8'), ('CL_0000084', 'T cell', 27, 'T cells'), ('PR_000000364', 'smad2', 50, 'Smad4'), ('GO_0006915', 'apoptotic process', 77, 'cell apoptosis')]
PMC4896250	4/2016	S7294-PMC4896250	['the obtained Sera were analysed for ova-specific Antibodies, while Spleen Cells were tested for T-Cell Responses including cytokine secretion after re-stimulation of the cells in vitro with ovalbumin.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 13, 'sera'), ('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('CL_0002240', 'marrow fibroblast', 67, 'spleen cells'), ('UBERON_0002106', 'spleen', 67, 'spleen'), ('CL_0000084', 'T cell', 96, 'T-cell'), ('GO_0001914', 'regulation of T cell mediated cytotoxicity', 96, 'T-cell responses')]
PMC4896250	4/2016	S7332-PMC4896250	['we evaluated Airway hyperresponsiveness (ahr), the proportion of Eosinophils in Bronchoalveolar Lavage Fluid (Balf), Lung histology, Serum total and ova-specific Antibody, cytokine profile of Balf and Lung draining Lymph Nodes (Lln), and T Cell population of lln.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 13, 'airway'), ('CL_0000771', 'eosinophil', 65, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 80, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 110, 'BALF'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0001977', 'blood serum', 133, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 162, 'antibody'), ('UBERON_0001348', 'brown adipose tissue', 192, 'BALF'), ('UBERON_0002048', 'lung', 201, 'lung'), ('UBERON_0000029', 'lymph node', 215, 'lymph nodes'), ('UBERON_2000120', 'lateral line ganglion', 228, 'LLN'), ('CL_0000084', 'T cell', 238, 'T cell')]
PMC4896250	4/2016	S7337-PMC4896250	['in addition, Cd25+Foxp3+and Il-10+T Cells in Lln were significantly increased after Ascs-derived secretome administration.']	N/A	N/A	[('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 13, 'CD25'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 18, 'Foxp3'), ('PR_000001470', 'interleukin-28B', 28, 'IL-10'), ('CL_0000084', 'T cell', 34, 'T cells'), ('UBERON_2000120', 'lateral line ganglion', 45, 'LLN'), ('CL_0002561', 'outer root sheath cell', 84, 'ASCs')]
PMC4896250	4/2016	S7692-PMC4896250	['A543 elevated Airway Cd45Ro Memory Cells in wheezing children with lower Respiratory infection\n\njungi choi1, yusok han1, jin-sung park1, eunmi kwon1, chang-keun kim2\n\n1sanggye paik hospital, south korea;2inje university sanggye paik hospital\n\ncorrespondence: jungi choi – sanggye paik hospital, south korea\nintroduction: no data on Airway T Cell subsets in “wheezing” children (wc) is available.']	N/A	N/A	[('PR_000002100', 'sodium channel protein type 4 subunit alpha', 0, 'A543'), ('UBERON_0001005', 'respiratory airway', 14, 'Airway'), ('PR_000005170', 'CD37 molecule', 21, 'CD45RO'), ('CL_0000845', 'marginal zone B cell of spleen', 28, 'Memory Cells'), ('GO_0007613', 'memory', 28, 'Memory'), ('UBERON_0001004', 'respiratory system', 73, 'Respiratory'), ('UBERON_0001005', 'respiratory airway', 332, 'airway'), ('CL_0000084', 'T cell', 339, 'T cell')]
PMC4896250	4/2016	S7698-PMC4896250	['cell blocks were cut and immunohistochemically stained for the following T Cell Surface markers: cd3, Cd4, Cd8, Cd25, and Cd45Ro.']	N/A	N/A	[('CL_0000084', 'T cell', 73, 'T cell'), ('GO_0009986', 'cell surface', 75, 'cell surface'), ('PR_000001204', 'C-C chemokine receptor type 8', 102, 'CD4'), ('PR_000005170', 'CD37 molecule', 107, 'CD8'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 112, 'CD25'), ('PR_000005170', 'CD37 molecule', 122, 'CD45RO')]
PMC4896250	4/2016	S7699-PMC4896250	['co-Expression of Cd25 or Cd45Ro on cd3, Cd4, and Cd8 T Cells was evaluated by an image analysis program on sequential sections.']	N/A	N/A	[('GO_0010467', 'gene expression', 3, 'expression'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 17, 'CD25'), ('PR_000005170', 'CD37 molecule', 25, 'CD45RO'), ('PR_000001204', 'C-C chemokine receptor type 8', 40, 'CD4'), ('PR_000005170', 'CD37 molecule', 49, 'CD8'), ('CL_0000084', 'T cell', 53, 'T cells')]
PMC4896250	4/2016	S7953-PMC4896250	['furthermore, ascs engraftment caused significant increases the Regulatory T Cells (Tregs) and Il-10+T Cells populations in Llns.']	N/A	N/A	[('CL_0000815', 'regulatory T cell', 63, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 63, 'regulatory'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 83, 'Tregs'), ('PR_000001470', 'interleukin-28B', 94, 'IL-10'), ('CL_0000084', 'T cell', 100, 'T cells'), ('UBERON_0000029', 'lymph node', 123, 'LLNs')]
PMC4896250	4/2016	S8533-PMC4896250	['mja contains an Immunosuppressant Tetrahydrocannabinolamine (Thc) impairing the immunological reactivity of the T-Killer Cells, Macrophages and T Lymphocytes and production of the immunoinhibitory helper T cells, type -2 cytokines, Interleukin-10 and Interleukin-4.']	N/A	N/A	[('CHEBI_35705', 'immunosuppressive agent', 16, 'immunosuppressant'), ('CHEBI_26895', 'tetracyclines', 34, 'tetrahydrocannabinolamine'), ('CHEBI_17855', 'triglyceride', 61, 'THC'), ('CL_0000590', 'small luteal cell', 112, 'T ... Killer cells'), ('CL_0000235', 'macrophage', 128, 'macrophages'), ('CL_0000084', 'T cell', 144, 'T lymphocytes'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 204, 'T'), ('PR_000001470', 'interleukin-28B', 232, 'interleukin-10'), ('PR_000001381', 'interleukin-2 receptor subunit beta', 251, 'interleukin-4')]
PMC4896250	4/2016	S9260-PMC4896250	['standard laboratory tests comprised Serum Iga, Igm, Igg and Igg subclasses, Nk, B and T Cell counts, Granulocyte, Leucocyte and Monocyte counts by facs analysis.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 36, 'serum'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 42, 'IgA'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 47, 'IgM'), ('GO_0071735', 'IgG immunoglobulin complex', 52, 'IgG'), ('GO_0071735', 'IgG immunoglobulin complex', 60, 'IgG'), ('CL_0002438', 'NK1.1-positive natural killer cell, mouse', 76, 'NK ...'), ('CL_0000969', 'regulatory B cell', 80, 'B ...'), ('CL_0000084', 'T cell', 86, 'T cell'), ('CL_0000094', 'granulocyte', 101, 'granulocyte'), ('CL_0000738', 'leukocyte', 114, 'leucocyte'), ('CL_0000576', 'monocyte', 128, 'monocyte')]
PMC4934634	11/2015	S104-PMC4934634	['the altered Cytokine Production In these cells leads to a shift in the Differentiation Of naïve T Cells from th1 to th2, wherein a weighted th2 response is associated with fetal tolerance, and Regulatory T Cells.']	N/A	N/A	[('GO_0006236', 'cytidine salvage', 12, 'cytokine production in'), ('GO_0030154', 'cell differentiation', 71, 'differentiation of ... T cells'), ('CL_0000084', 'T cell', 96, 'T cells'), ('CL_0000815', 'regulatory T cell', 193, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 193, 'regulatory')]
PMC4979151	8/2016	S2-PMC4979151	['in a subset of participants ( n \u2009=\u200980), Cord Blood Mononuclear Cells (cbmc) were cultured, non-adherent Lymphocytes were isolated to assess T Cell Cytokine Responses to Phytohemagglutinin (pha) and anti-cd3/anti-Cd28 (Icd3/Icd28), measured by multiplex assay.']	N/A	N/A	[('CL_0000752', 'cone retinal bipolar cell', 40, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('GO_0031097', 'medial cortex', 51, 'mononuclear'), ('CL_0000542', 'lymphocyte', 104, 'lymphocytes'), ('CL_0000084', 'T cell', 140, 'T cell'), ('GO_0001801', 'positive regulation of type IIb hypersensitivity', 147, 'cytokine responses'), ('CHEBI_52428', 'phenethicillin(1-)', 169, 'phytohemagglutinin'), ('PR_000001309', 'CD70 molecule', 212, 'CD28'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 218, 'iCD3'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 223, 'iCD28')]
PMC4979151	8/2016	S39-PMC4979151	['the non-adherent Lymphocytes, which consisted predominantly of 70–75\xa0% of T Lymphocyte (cd3), 20–23\xa0% of B Lymphocytes (Cd19) and 5–7\xa0% of Natural Killer Cells (cd16) were separated from adherent Monocytes (cd14) (10–15\xa0% in total cbmc), and cultured in presence of stimulants (T Cell Mitogen phytohemagglutinin (Pha) or agonistic Antibodies to T-Cell receptor).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 17, 'lymphocytes'), ('CL_0000084', 'T cell', 74, 'T lymphocyte'), ('CL_0000236', 'B cell', 105, 'B lymphocytes'), ('PR_000001309', 'CD70 molecule', 120, 'CD19'), ('CL_0000623', 'natural killer cell', 139, 'Natural killer cells'), ('CL_0000576', 'monocyte', 196, 'monocytes'), ('CL_0000084', 'T cell', 278, 'T cell'), ('CHEBI_52290', 'mitogen', 285, 'mitogen'), ('CHEBI_34926', 'Pitrazepin', 313, 'PHA'), ('GO_0042571', 'immunoglobulin complex, circulating', 331, 'antibodies'), ('CL_0000084', 'T cell', 345, 'T-cell'), ('GO_0005622', 'intracellular anatomical structure', 346, '-cell')]
PMC4979151	8/2016	S40-PMC4979151	['Stimulation Of Lymphocytes\nstimulation with anti-cd3 and anti-Cd28 Antibodies predominantly activates T Lymphocytes.']	N/A	N/A	[('GO_0016445', 'somatic diversification of immunoglobulins', 0, 'Stimulation of lymphocytes'), ('CL_0000542', 'lymphocyte', 15, 'lymphocytes'), ('PR_000001309', 'CD70 molecule', 62, 'CD28'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies'), ('CL_0000084', 'T cell', 102, 'T lymphocytes')]
PMC4979151	8/2016	S44-PMC4979151	['after Pha stimulation the Stimulated Lymphocytes were harvested by centrifugation, stored in rnalater (qiagen gmbh, hilden, germany) for further use for evaluating T Lymphocyte Activation markers by pcr array.']	N/A	N/A	[('CHEBI_34926', 'Pitrazepin', 6, 'PHA'), ('CL_0002651', 'endothelial cell of venous sinus of spleen', 26, 'stimulated'), ('CL_0000542', 'lymphocyte', 37, 'lymphocytes'), ('CL_0000084', 'T cell', 164, 'T lymphocyte'), ('GO_0042110', 'T cell activation', 164, 'T lymphocyte activation')]
PMC4979151	8/2016	S100-PMC4979151	['compared to unstimulated control Lymphocytes, Pha stimulation significantly down-regulated many C-C Chemokine receptors (Ccr1, Ccr2, Ccr3 and Ccr5), multiple toll-like receptors (tlrs)(Tlr1, Tlr2, Tlr4, Tlr6, Tlr9), Cxcr4, Clec7A (C-Type Lectin Domain Family 7, Member A), Socs5 (Suppressor Of Cytokine Signaling 55), Icoslg (Inducible T-Cell Co-Stimulator Ligand), Cd3D and Cd3G (subunits in cd3-T Cell receptor Complex), Cd8B (B Subunit On Cytotoxic T Cells), Cd81 (Expressed on T Lymphocytes), Tgf-Β, Ifngr1, Ifngr2 (receptors of ifn-γ), Hla-Dr, Nck1, Nck2, and Histone deacetylases (Hdac4-9) (fig.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 33, 'lymphocytes'), ('CHEBI_34926', 'Pitrazepin', 46, 'PHA'), ('PR_000004915', 'carbonic anhydrase 12', 96, 'C-C'), ('CHEBI_28969', 'N,N-dimethyltryptamine', 100, 'chemokine'), ('PR_000001204', 'C-C chemokine receptor type 8', 121, 'CCR1'), ('PR_000001204', 'C-C chemokine receptor type 8', 127, 'CCR2'), ('PR_000001204', 'C-C chemokine receptor type 8', 133, 'CCR3'), ('PR_000001204', 'C-C chemokine receptor type 8', 142, 'CCR5'), ('PR_000001155', 'Toll-like receptor 4', 185, 'TLR1'), ('PR_000001155', 'Toll-like receptor 4', 191, 'TLR2'), ('PR_000001155', 'Toll-like receptor 4', 197, 'TLR4'), ('PR_000001155', 'Toll-like receptor 4', 203, 'TLR6'), ('PR_000001155', 'Toll-like receptor 4', 209, 'TLR9'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 216, 'CXCR4'), ('PR_000005563', 'C-type lectin domain family 18 member C', 223, 'CLEC7A'), ('PR_000029352', 'centrosomal protein of 85 kDa', 231, 'C-type lectin domain family 7, member A'), ('SO_0000417', 'polypeptide_domain', 245, 'domain'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 273, 'SOCS5'), ('PR_000015319', 'snRNA-activating protein complex subunit 4', 280, 'Suppressor of cytokine signaling 55'), ('GO_0019221', 'cytokine-mediated signaling pathway', 294, 'cytokine signaling'), ('PR_000008898', 'immediate early response 3-interacting protein 1', 318, 'ICOSLG'), ('PR_000008893', 'isopentenyl-diphosphate Delta-isomerase 2', 326, 'Inducible T-cell co-stimulator ligand'), ('CL_0000084', 'T cell', 336, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 337, '-'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 366, 'CD3D'), ('PR_000005170', 'CD37 molecule', 375, 'CD3G'), ('CL_0000918', 'Tc2 cell', 397, 'T Cell'), ('GO_0032991', 'protein-containing complex', 413, 'complex'), ('PR_000005170', 'CD37 molecule', 423, 'CD8B'), ('PR_000002195', 'caspase-1-like protease', 429, 'B subunit on'), ('CL_0000910', 'cytotoxic T cell', 442, 'cytotoxic T cells'), ('GO_0043066', 'negative regulation of apoptotic process', 442, 'cytotoxic'), ('PR_000016001', 'T-box transcription factor T', 452, 'T'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 462, 'CD81'), ('GO_0010467', 'gene expression', 468, 'expressed'), ('CL_0000084', 'T cell', 481, 'T lymphocytes'), ('PR_000000046', 'TGF-beta', 497, 'TGF-β'), ('PR_000008920', 'interferon alpha-7', 504, 'IFNGR1'), ('PR_000008920', 'interferon alpha-7', 512, 'IFNGR2'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 541, 'HLA-DR'), ('PR_000011040', 'nuclear receptor coactivator 1', 549, 'NCK1'), ('PR_000011040', 'nuclear receptor coactivator 1', 555, 'NCK2'), ('CHEBI_15358', 'histone', 565, 'histone'), ('PR_000043452', 'core histone', 565, 'histone'), ('PR_000008488', 'histone deacetylase 9', 587, 'HDAC4')]
PMC4979151	8/2016	S121-PMC4979151	['supplementation of healthy women with oral vitd3for 6\xa0months did not lead to significant alterations in Expression of Ifn-Γ and Il-4 cytokines compared to placebo group, nor were there any effects on transcription factors T-Bet and Gata3, that Regulate the th1/th2 fate Of Cd4+T Cells [22].']	N/A	N/A	[('GO_0010467', 'gene expression', 104, 'expression'), ('PR_000008920', 'interferon alpha-7', 118, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 128, 'IL-4'), ('PR_000016190', 'trichohyalin-like protein 1', 222, 'T-bet'), ('PR_000007857', 'erythroid transcription factor', 232, 'GATA3'), ('GO_0065007', 'biological regulation', 244, 'regulate'), ('GO_0007608', 'sensory perception of smell', 270, 'of ...'), ('CL_0000476', 'thyrotroph', 273, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 273, 'CD4'), ('CL_0000084', 'T cell', 277, 'T cells'), ('GO_0007567', 'parturition', 279, 'cells')]
PMC4979151	8/2016	S165-PMC4979151	['abbreviations\n25(Oh)D3, 25-Hydroxy-Vitamin D3; cba, cytometric bead array; Cbmc, Cord Blood Mononuclear Cells; ccrs, c-C chemokine Receptors; hdac, Histone deacetylases; Icd3/Icd28, anti-cd3/anti-Cd28; Pha, Phytohemagglutinin; Tcr, T Cell Receptor Complex; Th, T Helper Cell type; tlrs, toll-like receptors; Tollip, Toll Interacting Protein; Treg, T Regulatory Cells; vitd3, Vitamin D3\n\npubmed central:']	N/A	N/A	[('CHEBI_62946', 'ammonium sulfate', 14, '25(OH)D3'), ('CHEBI_70487', '(-)-sanguinolignan C', 24, '25-hydroxy-'), ('CHEBI_33279', 'vitamin D5', 35, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 35, 'vitamin D3'), ('CL_0002062', 'type I pneumocyte', 75, 'CBMC'), ('CL_0000752', 'cone retinal bipolar cell', 81, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 81, 'cord'), ('UBERON_0000178', 'blood', 86, 'blood'), ('GO_0031097', 'medial cortex', 92, 'mononuclear'), ('PR_000004900', 'complement C3', 119, 'C'), ('PR_000014368', 'RuvB-like 1', 131, 'receptors'), ('CHEBI_15358', 'histone', 148, 'histone'), ('PR_000043452', 'core histone', 148, 'histone'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 170, 'iCD3'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 175, 'iCD28'), ('PR_000001309', 'CD70 molecule', 196, 'CD28'), ('CHEBI_34926', 'Pitrazepin', 202, 'PHA'), ('CHEBI_52428', 'phenethicillin(1-)', 207, 'phytohemagglutinin'), ('CL_0000084', 'T cell', 227, 'TCR'), ('CL_0000084', 'T cell', 232, 'T cell'), ('GO_0043235', 'receptor complex', 239, 'receptor complex'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 257, 'Th'), ('CL_0000912', 'helper T cell', 261, 'T helper cell'), ('PR_000016529', 'target of Myb protein 1', 308, 'TOLLIP'), ('PR_000016848', 'DNA-directed RNA polymerase I subunit RPA43', 316, 'toll interacting protein'), ('CL_0000901', 'Tr1 cell', 342, 'Treg'), ('CL_0000902', 'induced T-regulatory cell', 348, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 350, 'regulatory'), ('CHEBI_33279', 'vitamin D5', 375, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 375, 'vitamin D3')]
PMC5161647	8/2016	S88-PMC5161647	['specifically, Igf2 Dna Methylation scores were residualized for estimated proportions of cells in whole Blood (proportion of Cd8+ T Cells, Cd4+ T Cells, natural Killer [Nk] Cells, B Cells, and Monocytes).']	N/A	N/A	[('PR_000008989', 'interleukin-1 family member 7', 14, 'IGF2'), ('GO_0006306', 'DNA methylation', 19, 'DNA methylation'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CL_0000820', 'B-1a B cell', 125, 'CD8 ...'), ('PR_000005170', 'CD37 molecule', 125, 'CD8'), ('CL_0000084', 'T cell', 130, 'T cells'), ('CL_0000476', 'thyrotroph', 139, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 139, 'CD4'), ('CL_0000084', 'T cell', 144, 'T cells'), ('CL_0011107', 'Muller cell', 161, 'killer ...'), ('CL_0002280', 'type N enteroendocrine cell', 169, 'NK ... cells'), ('GO_0005634', 'nucleus', 169, 'NK'), ('CL_0000236', 'B cell', 180, 'B cells'), ('CL_0000576', 'monocyte', 193, 'monocytes')]
PMC5183755	12/2016	S61-PMC5183755	['estimated Blood Cell percentages and Naïve T Cell abundance\nin five illumina 450k datasets (datasets 6–10), we also considered the proportions of Cd8 T Cells, cd4 T Cells, Natural Killer Cells, and B Cells, and the abundance of defined different subtypes of T Cells: Naive T Cells = Cd45Ra+Ccr7+ and Memory T Cells = cd45ro+.']	N/A	N/A	[('CL_0000081', 'blood cell', 10, 'Blood Cell'), ('UBERON_0000178', 'blood', 10, 'Blood'), ('CL_0000898', 'naive T cell', 37, 'Naïve T cell'), ('CL_0000920', 'CD8-positive, CD28-negative, alpha-beta regulatory T cell', 146, 'CD8 T cells'), ('CL_0000084', 'T cell', 163, 'T cells'), ('CL_0000623', 'natural killer cell', 172, 'natural killer cells'), ('CL_0000236', 'B cell', 198, 'B cells'), ('CL_0000084', 'T cell', 258, 'T cells'), ('CL_0000898', 'naive T cell', 267, 'naive T cells'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 283, 'CD45RA'), ('PR_000001204', 'C-C chemokine receptor type 8', 290, 'CCR7'), ('CL_0000813', 'memory T cell', 300, 'memory T cells'), ('GO_0007613', 'memory', 300, 'memory')]
PMC5183755	12/2016	S82-PMC5183755	['Lymphocyte subsets were categorized according to following definitions: T Cells (cd3+), B Cells (Cd19+), Nk Cells (cd16+/Cd56+), naïve (Cd45Ra+Ccr7+Cd27+) Cd4+or Cd8+T Cells, and Memory (Cd45Ro+) Cd4+or Cd8+T Cells.']	N/A	N/A	[('CL_0000824', 'mature natural killer cell', 0, 'Lymphocyte'), ('CL_0000084', 'T cell', 72, 'T cells'), ('CL_0000236', 'B cell', 88, 'B cells'), ('PR_000001309', 'CD70 molecule', 97, 'CD19'), ('CL_0000623', 'natural killer cell', 105, 'NK cells'), ('GO_0005634', 'nucleus', 105, 'NK'), ('PR_000001309', 'CD70 molecule', 121, 'CD56'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 136, 'CD45RA'), ('PR_000001204', 'C-C chemokine receptor type 8', 143, 'CCR7'), ('PR_000001309', 'CD70 molecule', 148, 'CD27'), ('PR_000001204', 'C-C chemokine receptor type 8', 155, 'CD4'), ('PR_000005170', 'CD37 molecule', 162, 'CD8'), ('CL_0000084', 'T cell', 166, 'T cells'), ('GO_0007613', 'memory', 179, 'memory'), ('PR_000005170', 'CD37 molecule', 187, 'CD45RO'), ('PR_000001204', 'C-C chemokine receptor type 8', 196, 'CD4'), ('PR_000005170', 'CD37 molecule', 203, 'CD8'), ('CL_0000084', 'T cell', 207, 'T cells')]
PMC5183755	12/2016	S88-PMC5183755	['in five illumina 450k datasets (datasets 6–10), the epigenetic clock software also allowed us to determine the ordinal abundance measures, proportions of Cd8+ t cells, cd4+ T Cells, Natural Killer Cells (Nk Cells), and B Cells, and different subtypes of T Cells, Naive T Cells (cd45ra+Ccr7+) and Memory and Effector T Cells (Cd8+Cd28–Cd45Ra–).']	N/A	N/A	[('PR_000005170', 'CD37 molecule', 154, 'CD8'), ('CL_0000084', 'T cell', 173, 'T cells'), ('CL_0000623', 'natural killer cell', 182, 'natural killer cells'), ('CL_0000623', 'natural killer cell', 204, 'NK cells'), ('CL_0000236', 'B cell', 219, 'B cells'), ('CL_0000084', 'T cell', 254, 'T cells'), ('CL_0000898', 'naive T cell', 263, 'naive T cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 285, 'CCR7'), ('CL_0000104', 'multipolar neuron', 296, 'memory ...'), ('GO_0007613', 'memory', 296, 'memory'), ('CL_0000911', 'effector T cell', 307, 'effector T cells'), ('PR_000005170', 'CD37 molecule', 325, 'CD8'), ('PR_000001309', 'CD70 molecule', 329, 'CD28'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 334, 'CD45RA')]
PMC5183755	12/2016	S121-PMC5183755	['the difference between newborns of nonsmoking and smoking mothers was statistically significant by t -test for means of estimated abundance measures of Naïve Cd8+ T Cells (294.50 ± 6.31 versus 261.82 ± 7.26, p = 0.003) and proportion of Plasma Blasts (2.11 ± 0.02 versus 2.20 ± 0.02, p = 0.016) (figure 4).']	N/A	N/A	[('CL_0000898', 'naive T cell', 152, 'naïve'), ('CL_0000820', 'B-1a B cell', 158, 'CD8 ...'), ('CL_0000084', 'T cell', 163, 'T cells'), ('UBERON_0001969', 'blood plasma', 237, 'plasma'), ('CL_0000055', 'non-terminally differentiated cell', 244, 'blasts')]
PMC5310660	1/2017	S49-PMC5310660	['the Vitamin D acts as an immunomodulator by inhibiting the Proliferation Of the T Cells, shifting the T-Cell population toward noninflammatory T Helper 2 (th2) and T-Regulatory Cells, and suppressing the transcription of Genes encoding key th1 pro-inflammatory cytokines [18].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0008283', 'cell proliferation', 59, 'proliferation of ... T cells'), ('CL_0000084', 'T cell', 80, 'T cells'), ('CL_0000084', 'T cell', 102, 'T-cell'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 143, 'T helper'), ('CL_0000901', 'Tr1 cell', 164, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 166, 'regulatory'), ('SO_0000704', 'gene', 221, 'genes')]
PMC5372327	3/2017	S38-PMC5372327	['on Adaptive Immunity, for example, Vitamin D acts by Regulating the Release Of pro-inflammatory Cytokines From Mononuclear Cells and inhibits T-Cell Proliferation through decreased th1 cytokine secretion [24–26].']	N/A	N/A	[('GO_0051866', 'general adaptation syndrome', 3, 'adaptive immunity'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0065007', 'biological regulation', 53, 'regulating'), ('GO_0071867', 'response to monoamine', 68, 'release of ... cytokines from ... cells'), ('CL_0000226', 'single nucleate cell', 111, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 111, 'mononuclear'), ('CL_0000084', 'T cell', 142, 'T-cell'), ('GO_0042098', 'T cell proliferation', 142, 'T-cell proliferation')]
PMC5482199	2/2017	S21-PMC5482199	['materials and methods\n\npreparation of Mcs and T-Cells\nHuman cb or Peripheral Blood (pb) for Mcs isolation was obtained according to the institution’s guidelines on Human ethics from healthy neonates who had no complications at the Delivery or from healthy Adult volunteers.']	N/A	N/A	[('CL_0000186', 'myofibroblast cell', 38, 'MCs'), ('CL_0000084', 'T cell', 46, 'T-cells'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'Human'), ('UBERON_0012101', 'perinatal stage', 66, 'peripheral blood'), ('CL_0000186', 'myofibroblast cell', 92, 'MCs'), ('NCBITaxon_9606', 'Homo sapiens', 164, 'human'), ('GO_0007567', 'parturition', 231, 'delivery'), ('UBERON_0007023', 'adult organism', 256, 'adult')]
PMC5482199	2/2017	S23-PMC5482199	['T-Cells were purified by removing adherent Monocytes in plastic Tissue-culture dishes and filtering the non-adherent Lymphocyte fraction through two cycles of Nylon wool columns using an established protocol [27].']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T-cells'), ('CL_0000576', 'monocyte', 43, 'monocytes'), ('UBERON_0000479', 'tissue', 64, 'tissue'), ('CL_0000542', 'lymphocyte', 117, 'lymphocyte'), ('CHEBI_25614', 'nylons', 159, 'nylon')]
PMC5482199	2/2017	S24-PMC5482199	['the T-Cell preparation was ≥95% pure and >99% viable as determined by facs analysis and trypan blue Dye exclusion assay respectively.']	N/A	N/A	[('CL_0000084', 'T cell', 4, 'T-cell'), ('CHEBI_37958', 'dye', 100, 'dye')]
PMC5482199	2/2017	S25-PMC5482199	['purified Cd4+T-Cells were isolated from cbmcs as previously described [17].']	N/A	N/A	[('CL_0000476', 'thyrotroph', 9, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 9, 'CD4'), ('CL_0000084', 'T cell', 13, 'T-cells')]
PMC5482199	2/2017	S26-PMC5482199	['preparation of cell lysate\ncb T-Cells were Lysed in 100 μl of cold Lysis buffer [20 mm Hepes, ph 7.4, 0.5% Np40 (v/v), 100 mm Nacl, 1 mm edta, 2 mm Na3Vo4, 2 mm Dtt, 1 mm Pmsf, 2 mm p -nitrophenylphosphate and 10 mg/ml each of Leupeptin, aprotinin, Pepstatin A and Benzamidine] for 2 h (4°c) with constant mixing.']	N/A	N/A	[('CL_0000084', 'T cell', 30, 'T-cells'), ('GO_0019835', 'cytolysis', 43, 'lysed'), ('GO_0019835', 'cytolysis', 67, 'lysis'), ('CHEBI_46756', 'HEPES', 87, 'Hepes'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 107, 'NP40'), ('CHEBI_26710', 'sodium chloride', 126, 'NaCl'), ('CHEBI_34739', 'equilenin', 148, 'Na3VO4'), ('CHEBI_18320', '1,4-dithiothreitol', 161, 'DTT'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 171, 'PMSF'), ('CHEBI_6426', 'leupeptin', 227, 'leupeptin'), ('CHEBI_7989', 'pepstatin A', 249, 'pepstatin A'), ('CHEBI_41033', 'benzamidine', 265, 'benzamidine')]
PMC5482199	2/2017	S29-PMC5482199	['measurement of Pkcζ levels\nPkcζ Expression in Neonatal T-Cells was analysed by western blot assay as described previously [22,28].']	N/A	N/A	[('PR_000003059', 'protein kinase C beta type', 15, 'PKCζ'), ('PR_000003059', 'protein kinase C beta type', 27, 'PKCζ'), ('GO_0010467', 'gene expression', 32, 'expression'), ('CL_0000540', 'neuron', 46, 'neonatal'), ('CL_0000084', 'T cell', 55, 'T-cells')]
PMC5482199	2/2017	S39-PMC5482199	['the Human T-Cell nucleofection kit was from amaxa (lonza, wakersville, md, u.s.a.).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('CL_0000084', 'T cell', 10, 'T-cell'), ('GO_0007568', 'aging', 10, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 11, '-')]
PMC5482199	2/2017	S41-PMC5482199	['after Transfection, T-Cells were cultured for 24 h before harvesting for maturation studies.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 6, 'transfection'), ('CL_0000084', 'T cell', 20, 'T-cells')]
PMC5482199	2/2017	S44-PMC5482199	['neonatal T-Cell Maturation assay\nHuman Cb T-Cells, including those which were deficient in Pkcζ, were maturated as previously described using Phytohaemagglutinin (Pha) and Il-2 [22,28].']	N/A	N/A	[('CL_0000084', 'T cell', 9, 'T-cell'), ('GO_0072678', 'T cell migration', 9, 'T-cell maturation'), ('NCBITaxon_10088', 'Mus <genus>', 33, 'Human'), ('CL_0000103', 'bipolar neuron', 39, 'CB'), ('CL_0000084', 'T cell', 42, 'T-cells'), ('PR_000003059', 'protein kinase C beta type', 91, 'PKCζ'), ('CHEBI_8048', 'phellamurin', 142, 'phytohaemagglutinin'), ('CHEBI_34926', 'Pitrazepin', 163, 'PHA'), ('PR_000001470', 'interleukin-28B', 172, 'IL-2')]
PMC5482199	2/2017	S48-PMC5482199	['responses of in vitro matured Cb T-Cells\nimmune Responses of in vitro maturated Human Neonatal T-Cells were induced by adding Pha and Pma and measuring Lymphocyte Proliferation by quantifying the uptake of tritiated thymidine (3H-tdr) and by the cytokine release in 72-h cultures [30].']	N/A	N/A	[('CL_0000103', 'bipolar neuron', 30, 'CB'), ('CL_0000084', 'T cell', 33, 'T-cells'), ('GO_0060033', 'anatomical structure regression', 48, 'responses'), ('NCBITaxon_9606', 'Homo sapiens', 80, 'human'), ('CL_0000540', 'neuron', 86, 'neonatal'), ('CL_0000084', 'T cell', 95, 'T-cells'), ('CHEBI_34926', 'Pitrazepin', 126, 'PHA'), ('CHEBI_34913', 'Phenbenzamine hydrochloride', 134, 'PMA'), ('CL_0000542', 'lymphocyte', 152, 'lymphocyte'), ('GO_0008283', 'cell proliferation', 163, 'proliferation'), ('CHEBI_29238', 'tritium atom', 227, '3H')]
PMC5482199	2/2017	S49-PMC5482199	['analysis of H3 and H4 Histone Acetylation levels in cb cd4+T-Cells\na neonatal cohort for the analysis of the Histone Acetylation derived from a previously conducted clinical trial, in which mothers were daily supplemented with either Fish Oil or placebo from 20 weeks of Gestation until Delivery [8].']	N/A	N/A	[('PR_000027594', 'histone H3', 12, 'H3'), ('GO_0000724', 'double-strand break repair via homologous recombination', 19, 'H4'), ('PR_000027547', 'histone H2A', 19, 'H4'), ('CHEBI_15358', 'histone', 22, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 22, 'histone acetylation'), ('PR_000043452', 'core histone', 22, 'histone'), ('CL_0000084', 'T cell', 59, 'T-cells'), ('CHEBI_15358', 'histone', 109, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 109, 'histone acetylation'), ('PR_000043452', 'core histone', 109, 'histone'), ('CHEBI_34766', 'Furamizole', 234, 'fish oil'), ('GO_0007565', 'female pregnancy', 271, 'gestation'), ('GO_0007567', 'parturition', 287, 'delivery')]
PMC5482199	2/2017	S50-PMC5482199	['Cd4+T-Cells were obtained from 70 neonates (placebo, n =34; Fish Oil, n= 36).']	N/A	N/A	[('CL_0000251', 'extramedullary cell', 0, 'CD4'), ('CL_0000084', 'T cell', 4, 'T-cells'), ('CHEBI_34766', 'Furamizole', 60, 'fish oil')]
PMC5482199	2/2017	S75-PMC5482199	['cb T-Cells were nucleofected with Pkcζ-specific Shrna or control Shrna on day 0.']	N/A	N/A	[('CL_0000084', 'T cell', 3, 'T-cells'), ('PR_000003059', 'protein kinase C beta type', 34, 'PKCζ'), ('SO_0002031', 'shRNA', 48, 'shRNA'), ('SO_0002031', 'shRNA', 65, 'shRNA')]
PMC5482199	2/2017	S84-PMC5482199	['direct Stimulation Of purified T-Cells was achieved by adding pha/pma.']	N/A	N/A	[('GO_0018982', 'vanillin metabolic process', 7, 'stimulation of ... T ... cells'), ('CL_0000084', 'T cell', 31, 'T-cells')]
PMC5482199	2/2017	S88-PMC5482199	['caption (fig): figure 2\nPkcζ Regulates T-Cell functional phenotype potential during Maturation Of Human Cb T-Cells in culture\nHuman Cb T-Cells were maturated to Cd45Ro+/ra–phenotype by culturing with addition of Pha (day 1) and Il-2 (day 3) over 7 days.']	N/A	N/A	[('PR_000003059', 'protein kinase C beta type', 24, 'PKCζ'), ('GO_0065007', 'biological regulation', 29, 'regulates'), ('CL_0000084', 'T cell', 39, 'T-cell'), ('GO_0016477', 'cell migration', 84, 'maturation of ... T ... cells'), ('NCBITaxon_9606', 'Homo sapiens', 98, 'human'), ('CL_0000103', 'bipolar neuron', 104, 'CB'), ('CL_0000084', 'T cell', 107, 'T-cells'), ('NCBITaxon_10088', 'Mus <genus>', 126, 'Human'), ('CL_0000103', 'bipolar neuron', 132, 'CB'), ('CL_0000084', 'T cell', 135, 'T-cells'), ('PR_000005170', 'CD37 molecule', 161, 'CD45RO'), ('CHEBI_34926', 'Pitrazepin', 212, 'PHA'), ('PR_000001470', 'interleukin-28B', 228, 'IL-2')]
PMC5482199	2/2017	S89-PMC5482199	['( a ) Pkcζ knockdown was achieved by nucleofection of cb T-Cells with specific Shrna.']	N/A	N/A	[('PR_000003059', 'protein kinase C beta type', 6, 'PKCζ'), ('CL_0000084', 'T cell', 57, 'T-cells'), ('SO_0002031', 'shRNA', 79, 'shRNA')]
PMC5482199	2/2017	S90-PMC5482199	['nucleofection with Pkcζ Shrna led to the loss of Pkcζ in T-Cells, as demonstrated by western blot of three separate cb samples.']	N/A	N/A	[('PR_000003059', 'protein kinase C beta type', 19, 'PKCζ'), ('SO_0002031', 'shRNA', 24, 'shRNA'), ('PR_000003059', 'protein kinase C beta type', 49, 'PKCζ'), ('CL_0000084', 'T cell', 57, 'T-cells')]
PMC5482199	2/2017	S91-PMC5482199	['( b ) evaluating day 8 of cultures for the level of T-Cell Maturation by the levels of Expression of Cd45Ra/Cd45Ro.']	N/A	N/A	[('CL_0000084', 'T cell', 52, 'T-cell'), ('GO_0072678', 'T cell migration', 52, 'T-cell maturation'), ('GO_0010467', 'gene expression', 87, 'expression'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 101, 'CD45RA'), ('PR_000005170', 'CD37 molecule', 108, 'CD45RO')]
PMC5482199	2/2017	S92-PMC5482199	['( c , d ) T-Cells developed on Pkcζ-deficient background and then stimulated with Pha/Pma were examined for (c) Proliferation and (d) cytokine (tnfα, Ifnγ and Il-13) production.']	N/A	N/A	[('CL_0000084', 'T cell', 10, 'T-cells'), ('PR_000003059', 'protein kinase C beta type', 31, 'PKCζ'), ('CHEBI_34926', 'Pitrazepin', 82, 'PHA'), ('CHEBI_34913', 'Phenbenzamine hydrochloride', 86, 'PMA'), ('GO_0008283', 'cell proliferation', 112, 'proliferation'), ('PR_000008920', 'interferon alpha-7', 150, 'IFNγ'), ('PR_000001470', 'interleukin-28B', 159, 'IL-13')]
PMC5482199	2/2017	S103-PMC5482199	['caption (fig): figure 3\nPkcζ Gene ( Prkcz ) Promoter Histone Acetylation levels in cb Cd4+T-Cells differ between offspring of mothers treated during Pregnancy with Fish Oil compared with placebo\ncb Cd4+T-Cells were obtained from 70 neonates (Placebo, n =34; Fish Oil, n =36) and chip assayed for Histone Acetylation at Promoters of Genes encoding Pkcζ ( Prkcz ), Il-13 ( Il13 ), T-Box 21 ( Tbx21 ) and Ifnγ ( ifng ).']	N/A	N/A	[('PR_000003059', 'protein kinase C beta type', 24, 'PKCζ'), ('SO_0000704', 'gene', 29, 'gene'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 36, 'PRKCZ'), ('SO_0000167', 'promoter', 44, 'promoter'), ('CHEBI_15358', 'histone', 53, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 53, 'histone acetylation'), ('PR_000043452', 'core histone', 53, 'histone'), ('CL_0000476', 'thyrotroph', 86, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 86, 'CD4'), ('CL_0000084', 'T cell', 90, 'T-cells'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy'), ('CHEBI_34766', 'Furamizole', 164, 'fish oil'), ('CL_0000251', 'extramedullary cell', 198, 'CD4'), ('PR_000001204', 'C-C chemokine receptor type 8', 198, 'CD4'), ('CL_0000084', 'T cell', 202, 'T-cells'), ('CHEBI_26130', 'biological pigment', 242, 'placebo'), ('CHEBI_34766', 'Furamizole', 258, 'fish oil'), ('CHEBI_15358', 'histone', 296, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 296, 'histone acetylation'), ('PR_000043452', 'core histone', 296, 'histone'), ('SO_0000167', 'promoter', 319, 'promoters'), ('SO_0000704', 'gene', 332, 'genes'), ('PR_000003059', 'protein kinase C beta type', 347, 'PKCζ'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 354, 'PRKCZ'), ('PR_000001470', 'interleukin-28B', 363, 'IL-13'), ('PR_000001470', 'interleukin-28B', 371, 'IL13'), ('PR_000002103', 'sodium channel protein type 8 subunit alpha', 379, 'T-box 21'), ('PR_000016112', 'TBC1 domain family member 3', 390, 'TBX21'), ('PR_000008920', 'interferon alpha-7', 402, 'IFNγ')]
PMC5482199	2/2017	S113-PMC5482199	['while mapks function normally in cb T-Cells, Pkc and P56Lck are deficient [22,48].']	N/A	N/A	[('CL_0000084', 'T cell', 36, 'T-cells'), ('PR_000012724', 'phosphatidylinositol 3-kinase regulatory subunit alpha', 45, 'PKC'), ('PR_000003030', 'focal adhesion kinase', 53, 'p56lck')]
PMC5482199	2/2017	S123-PMC5482199	['this process, characterized by the unequal apportioning of cellular contents of the parent T-Cell into the two daughter cells, enables Lymphocyte fates to diverge early in an Immune Response when T-Cells are first stimulated by accessory cells [49,50].']	N/A	N/A	[('CL_0000084', 'T cell', 91, 'T-cell'), ('CL_0000542', 'lymphocyte', 135, 'lymphocyte'), ('GO_0006955', 'immune response', 175, 'immune response'), ('UBERON_0002405', 'immune system', 175, 'immune'), ('CL_0000084', 'T cell', 196, 'T-cells')]
PMC5513133	7/2017	S55-PMC5513133	['for example, 1,25(Oh)2D suppresses T Cell receptor-induced T Cell Proliferation, altering the cytokine Expression profile and diminishing the production of γ-interferon and Interleukin-2 [51].']	N/A	N/A	[('CHEBI_82784', 'PVP38-Ag NP', 13, '1,25(OH)2D'), ('CL_0000084', 'T cell', 35, 'T cell'), ('GO_0007265', 'Ras protein signal transduction', 35, 'T cell ... - ...'), ('CL_0000084', 'T cell', 59, 'T cell'), ('GO_0042098', 'T cell proliferation', 59, 'T cell proliferation'), ('GO_0010467', 'gene expression', 103, 'expression'), ('PR_000001381', 'interleukin-2 receptor subunit beta', 173, 'interleukin-2')]
PMC5526786	8/2017	S41-PMC5526786	['the mechanism by which Salt is able to induce Th17 Polarisation by T Lymphocytes is via P38/mapk and Nfat5 as well as Serum/Glucocorticoid-Regulated kinase 1 (Sgk-1) dependent signalling[23],[24].']	N/A	N/A	[('CHEBI_24866', 'salt', 23, 'salt'), ('GO_0072553', 'terminal button organization', 46, 'Th17 polarisation'), ('CL_0000084', 'T cell', 67, 'T lymphocytes'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 88, 'p38'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 101, 'NFAT5'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_24261', 'glucocorticoid', 124, 'glucocorticoid'), ('GO_0065007', 'biological regulation', 139, 'regulated'), ('PR_000014828', 'SH3 domain-containing kinase-binding protein 1', 159, 'SGK-1')]
PMC5679631	11/2017	S124-PMC5679631	['this leads to increased secretion of Interleukin 10 (Il-10), favoring the induction of Regulatory T Cells and their production of Il-10, over inflammatory T Cell formation [11].']	N/A	N/A	[('PR_000008988', 'interleukin-1 family member 5', 37, 'interleukin 10'), ('PR_000001470', 'interleukin-28B', 53, 'IL-10'), ('CL_0000815', 'regulatory T cell', 87, 'regulatory T cells'), ('GO_0043277', 'apoptotic cell clearance', 87, 'regulatory T cells'), ('PR_000001470', 'interleukin-28B', 130, 'IL-10'), ('CL_0000084', 'T cell', 155, 'T cell')]
PMC5716389	9/2017	S57-PMC5716389	['the number of Circulating T Cells and in vitro response to Mitogens were found to be significantly reduced in children with iron deficiency and anemia [41–43].']	N/A	N/A	[('CL_0000080', 'circulating cell', 14, 'circulating'), ('CL_0000084', 'T cell', 26, 'T cells'), ('CHEBI_52290', 'mitogen', 59, 'mitogens')]
PMC5941617	5/2018	S334-PMC5941617	['supplementation increased 25(Oh)D and 1,25(Oh)2D concentrations and decreased Pth levels but had no effect on Cd4+ T-Lymphocyte count.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('CHEBI_37958', 'dye', 38, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 40, '25(OH)2D'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 78, 'PTH'), ('CL_0000476', 'thyrotroph', 110, 'CD4 ...'), ('CL_0000084', 'T cell', 115, 'T-lymphocyte')]
